- A new chain pharmacy is preparing to open and a manager asks which federal application establishes the store's authority to dispense controlled substances. Which form is the correct answer?
- DEA Form 224
- DEA Form 222
- DEA Form 41
- DEA Form 106
Correct answer: DEA Form 224
DEA Form 224 is the new-registration application a retail pharmacy uses to obtain authority to dispense controlled substances. The order form for Schedule II drugs, the destruction record form, and the theft-or-loss report form each serve unrelated controlled-substance functions and do not register a pharmacy.
- A pharmacy that has held its DEA registration for three years receives a renewal notice. How often must a pharmacy's DEA registration generally be renewed?
- Every year
- Every three years
- Every five years
- Only once, because it never expires
Correct answer: Every three years
A pharmacy's DEA registration is renewed on a three-year cycle. An annual cycle is too frequent, a five-year cycle is too long, and the registration does not last indefinitely without renewal; the three-year renewal interval is the established federal requirement for a dispensing registrant.
- A pharmacy student preparing for licensure asks what the abbreviation 'DEA' refers to in the context of pharmacy registration. Which agency is it?
- Department of Education Affairs
- Drug Evaluation Authority
- Drug Enforcement Administration
- Dispensing and Enforcement Agency
Correct answer: Drug Enforcement Administration
DEA stands for the Drug Enforcement Administration, the federal agency that registers pharmacies and practitioners to handle controlled substances. The other expansions are invented labels that do not name the agency responsible for controlled-substance registration under federal law.
- A pharmacy completes its initial controlled-substance registration application and lists schedules II through V. Which separate federal credential category would a business need if it instead intended to manufacture controlled substances rather than dispense them?
- A dispenser registration on the pharmacy application
- No registration at all
- A practitioner registration
- A manufacturer registration, which is a different registrant category
Correct answer: A manufacturer registration, which is a different registrant category
Manufacturing controlled substances requires a manufacturer registration, a distinct registrant category from a dispensing pharmacy. The dispenser registration covers dispensing, not manufacturing; operating with no registration is unlawful; and a practitioner registration applies to individual prescribers, not a manufacturing operation.
- A wholesaler ships controlled substances to a pharmacy. Which credential must the pharmacy hold for the wholesaler to lawfully distribute Schedule II products to it?
- A current and valid DEA registration authorizing those schedules
- A business tax certificate only
- A signed lease for the building
- A pharmacist's personal continuing education record
Correct answer: A current and valid DEA registration authorizing those schedules
The pharmacy must hold a current, valid DEA registration covering the relevant schedules before a wholesaler may distribute Schedule II products to it. A tax certificate, a building lease, and a pharmacist's continuing education record do not establish the federal controlled-substance authority that distribution depends upon.
- A pharmacy's DEA registration certificate lists a specific business activity and schedules. If the pharmacy wants to begin handling a schedule not currently authorized on its registration, what must occur first?
- Nothing, because all pharmacies may handle all schedules automatically
- The registration must be modified to add the schedule before that schedule is handled
- The pharmacy may handle the new schedule for 90 days before updating
- The state board must reissue the pharmacy permit
Correct answer: The registration must be modified to add the schedule before that schedule is handled
Adding a schedule requires modifying the existing registration before the pharmacy handles drugs in that schedule. Pharmacies are not automatically authorized for every schedule, there is no 90-day window to handle an unauthorized schedule, and modifying the federal registration is separate from the state pharmacy permit.
- A pharmacy registrant wants a designated pharmacist to be able to sign for Schedule II orders. Which instrument grants that authority to the individual?
- The pharmacist's diploma
- A purchase order from the wholesaler
- A power of attorney executed by the registrant
- The pharmacy's business license
Correct answer: A power of attorney executed by the registrant
A power of attorney executed by the registrant is the instrument that authorizes a specific individual to sign Schedule II orders on the registrant's behalf. A diploma, a wholesaler purchase order, and the pharmacy's business license do not confer authority to execute controlled-substance order forms.
- A pharmacy maintains powers of attorney for Schedule II ordering. During an inspection, where must the registrant be able to make these documents available?
- Only at corporate legal counsel's office
- Filed exclusively with the state attorney general
- They need not be retained once signed
- At the registered location, available for inspection
Correct answer: At the registered location, available for inspection
Powers of attorney for ordering controlled substances must be kept at the registered location and available for inspection alongside other controlled-substance records. Storing them solely at outside legal counsel, filing them only with the attorney general, or failing to retain them would not satisfy the requirement that they be available at the registrant's location.
- A candidate has graduated from an accredited pharmacy program and passed the national clinical competency examination. Which additional examination must they typically pass before a state will license them?
- A second clinical competency examination
- A pharmacy law (jurisprudence) examination for that state
- A pharmacy technician certification examination
- A medical board licensing examination
Correct answer: A pharmacy law (jurisprudence) examination for that state
Candidates must also pass a pharmacy law, or jurisprudence, examination covering the laws of the state where they seek licensure. A repeat clinical exam, a technician certification, and a medical licensing exam are not the standard additional examination required for pharmacist licensure.
- A pharmacist completes continuing education courses each renewal period. What is the primary purpose of mandatory continuing education for licensure?
- To generate revenue for course vendors
- To replace the original pharmacy degree
- To maintain ongoing professional competency over the career
- To reduce the number of pharmacists in the workforce
Correct answer: To maintain ongoing professional competency over the career
Mandatory continuing education exists to keep pharmacists competent and current throughout their careers, protecting patient safety. Generating vendor revenue, replacing the original degree, and reducing the workforce are not the policy purposes behind continuing education requirements for license maintenance.
- A pharmacist measures continuing education in standardized units of credit. One contact hour of accredited continuing pharmacy education most commonly equals how much credit?
- 1.0 continuing education unit (CEU)
- 10 continuing education units (CEU)
- It cannot be expressed in CEUs
- 0.1 continuing education unit (CEU)
Correct answer: 0.1 continuing education unit (CEU)
One contact hour of continuing pharmacy education equals 0.1 continuing education unit, since one CEU represents ten contact hours. The figures of 1.0 and 10 CEUs overstate the value of a single hour, and continuing education hours are routinely expressed in CEUs, so they can be converted.
- A pharmacist allows their license to lapse for an extended period and now wants to return to practice. What is the most accurate description of returning to active status?
- Reactivation requires meeting the board's reinstatement conditions, which may include making up continuing education and paying fees
- The license reactivates automatically the moment the pharmacist returns to work
- A lapsed license can never be returned to active status
- Paying a small flat fee instantly restores full active status with no other conditions
Correct answer: Reactivation requires meeting the board's reinstatement conditions, which may include making up continuing education and paying fees
Returning a lapsed license to active status requires satisfying the board's reinstatement conditions, often including making up continuing education and paying applicable fees. Reactivation is not automatic on returning to work, a lapsed license is generally not permanently barred from reactivation, and a single small fee alone does not restore status without meeting the other conditions.
- A pharmacist seeks licensure in a second state by transferring an existing license rather than starting over. What is this transfer process commonly called?
- Initial licensure by examination
- License reciprocity or transfer of licensure
- Provisional internship registration
- Disciplinary reinstatement
Correct answer: License reciprocity or transfer of licensure
Obtaining a license in a second state by transferring an existing license is commonly called reciprocity, or transfer of licensure. Initial licensure by examination applies to first-time candidates, provisional internship registration concerns trainees, and disciplinary reinstatement involves restoring a previously disciplined license.
- A pharmacist is selected for a continuing education audit. The board asks for proof of the hours reported at the last renewal. How long should a pharmacist generally retain continuing education records to respond to such audits?
- Only until the renewal is submitted, then they may be discarded
- For exactly thirty days after each course
- For the period the board specifies, typically spanning recent renewal cycles
- Records never need to be retained because the provider keeps them
Correct answer: For the period the board specifies, typically spanning recent renewal cycles
Pharmacists should retain continuing education documentation for the period the board specifies, which typically covers recent renewal cycles so the records are available for audit. Discarding them at submission, keeping them only thirty days, or relying solely on the provider would leave the pharmacist unable to substantiate the hours during an audit.
- A pharmacy intern is logging supervised practice hours required for licensure. Under whose direct supervision must these internship hours generally be earned?
- A certified pharmacy technician
- The store's general manager
- A licensed prescriber outside the pharmacy
- A licensed pharmacist serving as preceptor
Correct answer: A licensed pharmacist serving as preceptor
Internship hours toward licensure must be earned under the direct supervision of a licensed pharmacist acting as preceptor. A technician, a store manager, and an outside prescriber are not qualified to supervise the professional internship experience that counts toward a pharmacist license.
- A pharmacist moves to a new home address but continues working at the same pharmacy. Regarding the individual's licensure record, what is the appropriate step?
- Notify the board of the address change within the required timeframe
- Do nothing, because only the pharmacy's address matters
- Surrender the license and reapply
- Report the move solely to the DEA
Correct answer: Notify the board of the address change within the required timeframe
Licensees must keep their personal information current, so a change in home address should be reported to the board within the required timeframe. Ignoring the change, surrendering and reapplying, and reporting only to the DEA do not satisfy the obligation to maintain accurate licensure records with the state board.
- A jurisdiction caps how many pharmacy technicians a single pharmacist may supervise at one time. What is this limit generally called?
- The dispensing fee schedule
- The pharmacist-to-technician ratio
- The formulary tier limit
- The prescription transfer cap
Correct answer: The pharmacist-to-technician ratio
A limit on how many technicians one pharmacist may supervise simultaneously is the pharmacist-to-technician ratio. A dispensing fee schedule concerns payment, a formulary tier limit concerns drug coverage, and a prescription transfer cap concerns moving prescriptions; none of these describe the supervision limit.
- A technician asks whether they may independently counsel a patient on a new prescription instead of the pharmacist. How should this be handled?
- Technicians may always counsel as long as they are certified
- Any staff member may counsel if the pharmacist is busy
- Patient counseling on therapy is a pharmacist function and may not be delegated to a technician
- Counseling may be skipped entirely if a technician is present
Correct answer: Patient counseling on therapy is a pharmacist function and may not be delegated to a technician
Counseling a patient on drug therapy requires professional judgment and is a pharmacist function that cannot be delegated to a technician. Certification does not authorize technicians to counsel, counseling cannot be passed to any staff member when the pharmacist is busy, and the counseling responsibility cannot simply be skipped because a technician is available.
- A pharmacy distinguishes between a registered pharmacy technician and a pharmacy technician trainee. What is the typical difference in their status?
- A trainee has more authority than a registered technician
- There is no difference; the terms are interchangeable
- A trainee may supervise registered technicians
- A trainee is working toward registration and usually has a more limited, time-bounded status, while a registered technician has met the board's requirements
Correct answer: A trainee is working toward registration and usually has a more limited, time-bounded status, while a registered technician has met the board's requirements
A trainee is in the process of qualifying and typically holds a more limited, time-limited status, whereas a registered technician has satisfied the board's requirements. A trainee does not have more authority than a registered technician, the terms are not interchangeable, and a trainee does not supervise registered technicians.
- A technician at a pharmacy receives an oral prescription called in by a physician's office for a non-controlled drug. May the technician take down this new oral prescription?
- Whether a technician may receive a new oral prescription depends on state board rules, which often reserve or restrict this function
- A technician may always take any oral prescription without limitation
- Only the front-store cashier may take oral prescriptions
- Oral prescriptions are never permitted for any drug
Correct answer: Whether a technician may receive a new oral prescription depends on state board rules, which often reserve or restrict this function
Whether a technician may accept a new oral prescription is governed by state board rules, which frequently reserve or restrict that function. Technicians do not have unlimited authority to take any oral prescription, a cashier is not the proper recipient, and oral prescriptions are permitted for many non-controlled drugs, so a blanket prohibition is incorrect.
- A pharmacy wants to expand technician duties to include final verification of certain refills (tech-check-tech). The lawfulness of this arrangement is determined primarily by what?
- The technician's personal preference
- State board regulations governing permissible technician functions
- The number of prescriptions filled per day
- The pharmacy's profit margin
Correct answer: State board regulations governing permissible technician functions
Whether tech-check-tech is permitted is determined primarily by the state board's regulations defining technician functions. A technician's preference, the daily prescription volume, and the pharmacy's profit margin do not establish legal authority for an expanded technician function the board has not approved.
- A pharmacist is asked whether they may diagnose a patient's medical condition and prescribe accordingly on their own authority. In most jurisdictions, how is this characterized?
- Pharmacists may diagnose and prescribe any drug for any condition independently
- Pharmacists may diagnose but never dispense
- Independent diagnosis and prescribing fall outside the typical pharmacist scope of practice
- Diagnosis is allowed only for controlled substances
Correct answer: Independent diagnosis and prescribing fall outside the typical pharmacist scope of practice
Independent diagnosis and unrestricted prescribing generally fall outside a pharmacist's scope of practice, which centers on dispensing and medication management. Pharmacists do not have unlimited authority to diagnose and prescribe, the claim that they may diagnose but never dispense is incorrect, and diagnosis is not specially permitted for controlled substances.
- A pharmacist enters into a written collaborative practice agreement with a physician. What does this agreement enable the pharmacist to do?
- Practice medicine without any physician involvement
- Override the physician's prescribing on unrelated patients
- Issue licenses to other pharmacists
- Initiate or modify drug therapy within protocols specified by the agreement
Correct answer: Initiate or modify drug therapy within protocols specified by the agreement
A collaborative practice agreement lets a pharmacist initiate or modify drug therapy within the protocols the agreement defines with the physician. It does not authorize practicing medicine independently, overriding prescribing for unrelated patients, or issuing licenses to other pharmacists.
- A pharmacy designates one pharmacist as the legally responsible party for the operation's regulatory compliance. What is this individual typically called?
- The pharmacist-in-charge
- The dispensing clerk
- The lead technician
- The pharmacy benefits manager
Correct answer: The pharmacist-in-charge
The pharmacist designated as legally responsible for a pharmacy's regulatory compliance is the pharmacist-in-charge. A dispensing clerk and a lead technician are support roles without that legal accountability, and a pharmacy benefits manager administers drug coverage rather than overseeing a pharmacy's compliance.
- A pharmacist concludes that a particular prescription should not be filled because it would be unsafe for the patient. What does the pharmacist's scope of practice generally permit here?
- The pharmacist must fill every prescription regardless of safety
- The pharmacist may refuse to dispense based on professional judgment that filling would be unsafe
- The pharmacist may refuse only with written board approval each time
- The pharmacist may refuse only if the patient agrees
Correct answer: The pharmacist may refuse to dispense based on professional judgment that filling would be unsafe
A pharmacist's professional scope includes refusing to dispense a prescription that professional judgment shows would be unsafe. The pharmacist is not required to fill every prescription regardless of safety, does not need written board approval for each refusal, and does not need the patient's agreement to decline an unsafe dispensing.
- A pharmacist wishes to administer vaccines to adult patients. Beyond holding an active license, what most directly authorizes this activity?
- Simply choosing to offer the service
- Obtaining a separate manufacturer registration
- Completing required immunization training and acting within the state-authorized scope and protocols
- Having a technician present in the room
Correct answer: Completing required immunization training and acting within the state-authorized scope and protocols
Pharmacist immunization authority depends on completing required training and operating within the state's authorized scope and protocols. Merely deciding to offer the service, obtaining a manufacturer registration, and having a technician present do not establish the legal authority to administer vaccines.
- A pharmacist holds final professional accountability for a dispensed prescription even though support staff prepared it. Which principle does this reflect?
- Equal legal accountability shared with the cashier
- Full transfer of responsibility to the preparing technician
- Responsibility resting with the drug manufacturer
- The pharmacist's ultimate professional responsibility over supervised personnel
Correct answer: The pharmacist's ultimate professional responsibility over supervised personnel
The pharmacist's ultimate professional responsibility over the work of supervised staff means accountability for the final product remains with the pharmacist. Responsibility is not equally shared with a cashier, not fully transferred to the preparing technician, and not shifted to the manufacturer for the act of dispensing.
- A pharmacy operates without a properly designated pharmacist-in-charge for an extended period. Why is this a regulatory problem?
- No pharmacist holds the legal accountability the law requires for the pharmacy's operation
- It prevents the pharmacy from advertising
- It increases the pharmacy's tax rate
- It voids the manufacturer warranties on stock
Correct answer: No pharmacist holds the legal accountability the law requires for the pharmacy's operation
Operating without a designated pharmacist-in-charge means no pharmacist holds the legal accountability the law requires for the pharmacy's lawful operation. Advertising limits, tax rates, and manufacturer warranties are not the regulatory concern created by the absence of a pharmacist-in-charge.
- A pharmacy operates in a setting where the only pharmacist on duty leaves the licensed area for a break. What does the supervision requirement generally demand regarding professional functions during that absence?
- Technicians may perform all pharmacist functions while the pharmacist is away
- Professional functions requiring a pharmacist must be paused or covered, because supportive personnel cannot perform them without pharmacist supervision
- The pharmacy may dispense controlled substances freely during the gap
- Any employee may counsel patients during the break
Correct answer: Professional functions requiring a pharmacist must be paused or covered, because supportive personnel cannot perform them without pharmacist supervision
When no pharmacist is present, functions requiring a pharmacist must be paused or covered because supportive personnel cannot lawfully perform them unsupervised. Technicians cannot assume all pharmacist functions, controlled substances cannot be freely dispensed without pharmacist oversight, and patient counseling cannot be done by any employee in the pharmacist's absence.
- A board receives a complaint and is considering whether to discipline a pharmacist. Before imposing serious sanctions, what procedural protection is the licensee generally entitled to?
- Immediate license destruction with no explanation
- A jury trial in criminal court
- Notice of the charges and an opportunity to be heard
- Approval from the pharmacy's competitors
Correct answer: Notice of the charges and an opportunity to be heard
Administrative due process generally entitles a licensee to notice of the charges and an opportunity to be heard before serious discipline. Sanctions are not imposed without explanation, a board proceeding is not a criminal jury trial, and competitor approval has no role in the disciplinary process.
- A board issues an order temporarily prohibiting a pharmacist from practicing for a fixed period, after which the license may resume. Which classification does this describe?
- Revocation
- Reprimand
- Denial of an initial application
- Suspension
Correct answer: Suspension
A temporary prohibition on practice for a fixed period, with the possibility of resuming afterward, is a suspension. Revocation permanently terminates the license, a reprimand is a formal rebuke that does not halt practice, and denial of an initial application concerns a new applicant rather than an existing license.
- A board permanently terminates a pharmacist's license after repeated serious violations. Which term names this most severe outcome?
- Revocation
- Probation
- Reprimand
- Continuing education deficiency notice
Correct answer: Revocation
Permanently terminating a license is revocation, the most severe disciplinary outcome. Probation allows continued practice under conditions, a reprimand is a formal rebuke that does not end the license, and a continuing education deficiency notice is a minor administrative matter rather than a permanent termination.
- A board allows a pharmacist to keep working but imposes conditions such as supervision and periodic reporting for a set time. Which disciplinary mechanism is this?
- Revocation
- Probation
- Voluntary surrender
- Summary suspension
Correct answer: Probation
Permitting continued practice under conditions like supervision and periodic reporting for a defined period is probation. Revocation ends the license, voluntary surrender relinquishes it, and a summary suspension halts practice rather than allowing supervised continued work.
- A board determines that a pharmacist committed a minor first violation and issues a formal written rebuke without restricting practice. What is this action called?
- A revocation
- An indefinite suspension
- A reprimand
- A practice ban
Correct answer: A reprimand
A formal written rebuke documenting a violation without restricting practice is a reprimand. Revocation, indefinite suspension, and a practice ban are more severe actions that restrict or end practice, which exceeds what a minor first violation typically warrants.
- A board learns that a pharmacist obtained their license by submitting falsified credentials. How does fraud in obtaining a license generally relate to disciplinary authority?
- Fraud is excused once the license has been issued
- Only the applicant's school may address the fraud
- Fraud is a concern only for technicians, not pharmacists
- Fraud in procuring a license is a recognized ground for disciplinary action, including revocation
Correct answer: Fraud in procuring a license is a recognized ground for disciplinary action, including revocation
Obtaining a license through fraud or misrepresentation is a recognized ground for discipline, up to revocation. The fraud is not excused once a license issues, it is not a matter left solely to the applicant's school, and it is not limited to technicians; it applies to pharmacist licensure as well.
- A pharmacist receives a final disciplinary order from the board and believes it was wrongly decided. What recourse is generally available?
- Pursue an appeal through the established administrative or judicial review process
- Ignore the order while continuing to practice
- Demand the DEA reverse the state board's order
- Petition customers to nullify the decision
Correct answer: Pursue an appeal through the established administrative or judicial review process
A licensee who disputes a final board order may pursue an appeal through the established administrative or judicial review process. Ignoring the order, asking the DEA to reverse a state board, and petitioning customers are not legitimate avenues to challenge a disciplinary decision.
- A board negotiates an agreement in which a pharmacist accepts specific sanctions without a full contested hearing. This negotiated resolution is best described as which type of order?
- A criminal plea bargain entered in court
- A consent order or stipulated agreement
- An automatic license renewal
- A continuing education waiver
Correct answer: A consent order or stipulated agreement
A negotiated disciplinary resolution in which the licensee accepts sanctions without a full hearing is a consent order, or stipulated agreement. It is not a criminal plea bargain, it is not an automatic renewal, and it is not a continuing education waiver, which address entirely different matters.
- A pharmacist voluntarily surrenders their license while a board investigation is pending. How is voluntary surrender best characterized relative to disciplinary action?
- It permanently shields the pharmacist from any record of the matter
- It guarantees automatic reinstatement after one year
- It is a relinquishment of the license that the board may treat as a disciplinary resolution and record accordingly
- It transfers the license to another pharmacist
Correct answer: It is a relinquishment of the license that the board may treat as a disciplinary resolution and record accordingly
Voluntary surrender is a relinquishment of the license that the board may treat as a disciplinary resolution and document in the licensee's record. It does not erase the matter from the record, does not guarantee automatic reinstatement, and a license cannot be transferred to another individual.
- An applicant for initial pharmacist licensure discloses a prior felony conviction on the application. How may the board treat this disclosure?
- The board must ignore all criminal history
- The conviction automatically grants the applicant a provisional license
- Only the police, not the board, may review the conviction
- The board may consider the conviction when evaluating the applicant's fitness and good moral character
Correct answer: The board may consider the conviction when evaluating the applicant's fitness and good moral character
A board may weigh a disclosed conviction when assessing an applicant's fitness and good moral character for licensure. The board does not ignore criminal history, a conviction does not grant a provisional license, and reviewing the disclosure for licensure purposes is within the board's authority rather than the police's alone.
- A pharmacy permit (license to operate as a pharmacy) is held by the establishment. How does this permit differ from the individual licenses of the pharmacists who work there?
- The permit authorizes the establishment to operate as a pharmacy, while individual licenses authorize each pharmacist to practice
- The permit replaces the need for any pharmacist licenses
- The permit is issued to each pharmacist personally
- The permit and a pharmacist license are the same credential
Correct answer: The permit authorizes the establishment to operate as a pharmacy, while individual licenses authorize each pharmacist to practice
A pharmacy permit licenses the establishment to operate as a pharmacy, whereas individual pharmacist licenses authorize the people to practice. The permit does not replace pharmacist licenses, is not issued to each pharmacist personally, and is not the same credential as an individual pharmacist license.
- A multistate pharmacy chain operates stores in several states. Regarding pharmacist licensure across those states, which statement is accurate?
- One pharmacist license is valid in all states automatically
- Each pharmacist must be licensed in every state where they practice
- Only the chain's headquarters state license is required
- Pharmacists need no state license if the chain holds a corporate license
Correct answer: Each pharmacist must be licensed in every state where they practice
A pharmacist must hold a license in each state where they practice, because pharmacist licensure is state-specific. A single license is not automatically valid nationwide, a headquarters-state license does not cover practice elsewhere, and a corporate license does not substitute for individual pharmacist licensure.
- A pharmacy intern who has not yet been issued a pharmacist license is asked to independently make the final clinical decision to dispense a prescription. Is this permissible?
- Yes, interns may independently make all final dispensing decisions
- Yes, as long as a technician double-checks the work
- No, the final clinical decision to dispense requires a licensed pharmacist, though the intern may perform functions under supervision
- Yes, if the prescription is for a non-controlled drug
Correct answer: No, the final clinical decision to dispense requires a licensed pharmacist, though the intern may perform functions under supervision
The final clinical decision to dispense is reserved to a licensed pharmacist; an intern may only perform functions under a pharmacist's supervision. Interns cannot independently make final dispensing decisions, a technician's double-check does not authorize it, and the limitation applies regardless of whether the drug is controlled.
- A pharmacist completes the licensure examinations and internship and receives the issued license from the board. At what point may the pharmacist begin practicing independently as a pharmacist?
- As soon as the examinations are passed, before the license is issued
- After obtaining a DEA registration, regardless of license status
- Immediately upon graduation from pharmacy school
- Once the board has issued the license
Correct answer: Once the board has issued the license
Independent pharmacist practice begins only once the board issues the license. Passing the exams before issuance, obtaining a DEA registration without the license, and graduating from pharmacy school are prerequisites or related steps but do not by themselves authorize independent practice.
- A pharmacy registrant learns that one of its authorized order-form signers has retired. To prevent future unauthorized ordering under that person's name, what should the registrant do?
- Execute a revocation of that individual's power of attorney
- Allow the authority to continue until it expires on its own
- Notify only the retiree, not document anything
- Transfer the retiree's signing authority to a clerk
Correct answer: Execute a revocation of that individual's power of attorney
The registrant should execute a revocation of the retiree's power of attorney so the person can no longer sign order forms. The authority does not safely lapse on its own, merely notifying the retiree without documentation is insufficient, and the signing authority cannot be transferred to a clerk.
- A pharmacy permanently closes. Regarding personnel authorized to sign controlled-substance order forms, what happens to those signing authorizations?
- The signers retain authority to order for any other pharmacy
- The powers of attorney become moot with the registration's termination, and any remaining controlled stock must be handled per disposal rules
- The authorizations transfer to the landlord
- The signers must keep ordering until inventory is sold
Correct answer: The powers of attorney become moot with the registration's termination, and any remaining controlled stock must be handled per disposal rules
When a pharmacy closes and terminates its registration, the order-form powers of attorney become moot and remaining controlled stock must be handled under disposal rules. The signers do not gain authority to order for other pharmacies, the authorizations do not pass to a landlord, and ordering does not continue to sell off inventory after closure.
- A board sets a minimum number of continuing education hours that must specifically address law or patient safety each renewal. What is the most accurate way to satisfy a topic-specific requirement?
- Count general hours toward the topic requirement regardless of subject
- Skip the topic requirement if total hours are met
- Complete accredited continuing education in the required subject area within the renewal period
- Substitute work experience for the required topic hours
Correct answer: Complete accredited continuing education in the required subject area within the renewal period
A topic-specific requirement is satisfied by completing accredited continuing education in that required subject within the renewal period. General hours in other subjects do not count toward a specific topic mandate, the topic requirement cannot be skipped merely because total hours are met, and work experience does not substitute for the required topic hours.
- A pharmacy registrant must ensure that only appropriate personnel access controlled substances. Why is controlling employee access considered part of the registrant's responsibilities?
- Employee access is solely the wholesaler's concern
- Access controls are optional once the pharmacy is registered
- Only the DEA, not the registrant, manages who accesses the stock
- Personnel security and limiting access help prevent diversion, which is a registrant responsibility
Correct answer: Personnel security and limiting access help prevent diversion, which is a registrant responsibility
Controlling which employees access controlled substances is a registrant responsibility because personnel security helps prevent diversion. Access control is not the wholesaler's sole concern, it is not optional after registration, and the day-to-day management of who accesses stock rests with the registrant rather than the DEA alone.
- A pharmacy holds a current pharmacy permit from the state and a current DEA registration. A patient asks why the pharmacy needs both. Which explanation is most accurate?
- The state permit authorizes operation as a pharmacy, while the DEA registration authorizes handling controlled substances
- The two are duplicates of the same authority
- The DEA registration alone authorizes the pharmacy to operate
- The state permit alone authorizes controlled-substance handling
Correct answer: The state permit authorizes operation as a pharmacy, while the DEA registration authorizes handling controlled substances
The state pharmacy permit authorizes the business to operate as a pharmacy, while the DEA registration separately authorizes handling controlled substances. The two are not duplicates, the DEA registration alone does not authorize general pharmacy operation, and the state permit alone does not confer federal controlled-substance authority.
- A pharmacist who is licensed in State A accepts a temporary assignment to work at a pharmacy in State B for two weeks. What does pharmacist licensure require for the State B work?
- The pharmacist's State A license automatically covers short assignments anywhere
- The pharmacist must hold a valid State B license to practice there
- No license is needed for assignments under thirty days
- Only the pharmacy permit, not a personal license, is required
Correct answer: The pharmacist must hold a valid State B license to practice there
The pharmacist must hold a valid license in State B to practice there, because pharmacist licensure is state-specific even for short assignments. A State A license does not automatically extend to other states, there is no general thirty-day exemption from licensure, and the pharmacy's permit does not substitute for the individual pharmacist's license.
- A pharmacy registrant must keep its DEA registration certificate available at the registered location. During an inspection, an inspector asks to see proof of the pharmacy's controlled-substance authority. What document satisfies this?
- The pharmacist-in-charge's personal continuing education transcript
- A copy of the wholesaler's invoice
- The current DEA registration certificate maintained at the registered location
- The building's certificate of occupancy
Correct answer: The current DEA registration certificate maintained at the registered location
The current DEA registration certificate kept at the registered location is what demonstrates the pharmacy's controlled-substance authority during inspection. A continuing education transcript, a wholesaler invoice, and a certificate of occupancy address other matters and do not prove federal controlled-substance registration.
- A pharmacist is reviewing the elements that every prescription must contain before it can be filled. Which of the following is a required identifying element of the prescriber rather than an optional convenience?
- The prescriber's name and address
- The prescriber's office decor description
- The prescriber's college graduation year
- The prescriber's preferred pharmacy chain
Correct answer: The prescriber's name and address
The prescriber's name and address is a required identifying element so the order can be attributed to and verified against an authorized practitioner. A graduation year, office decor, and a preferred pharmacy chain are not required prescription elements and do not establish who issued the order.
- A pharmacy receives a prescription on which the strength of the medication is left blank, though the drug name and directions are present. Why does the missing strength prevent the order from being dispensable as written?
- Because the strength sets the patient's copay
- Because the strength determines the pharmacy's reorder point
- Because without the strength the specific product to dispense is not defined
- Because the strength identifies the manufacturer's plant
Correct answer: Because without the strength the specific product to dispense is not defined
The strength is a required element because it defines exactly which product the pharmacist must dispense, and a blank strength leaves the order incomplete. The strength does not set a copay, determine a reorder point, or identify a manufacturing plant.
- A pharmacist receives a prescription that is clearly legible and complete in every element but appears to have been issued for a person other than the one presenting it, with no indication the presenter is an authorized agent. What validity concern does this raise?
- The drug's expiration date
- Whether the order is truly intended for an identified, legitimate patient
- The wholesaler's invoice number
- The font used on the printout
Correct answer: Whether the order is truly intended for an identified, legitimate patient
The concern is whether the prescription is genuinely intended for an identified, legitimate patient, since a valid prescription must be issued for a specific patient's medical need. The drug's expiration date, the wholesaler invoice, and the printout font are unrelated to whether the order names a legitimate patient.
- A pharmacist receives a non-controlled prescription transmitted by fax directly from the prescriber's office. Regarding validity, how should this faxed order generally be treated?
- As invalid because only paper originals count
- As requiring a separate mailed original within 24 hours
- As valid only if the patient also signs it
- As a valid means of transmitting a non-controlled order when it contains the required elements
Correct answer: As a valid means of transmitting a non-controlled order when it contains the required elements
A fax sent from the prescriber's office is a valid way to transmit a non-controlled prescription as long as it includes the required elements. It is not rendered invalid simply for being a fax, does not require a patient signature, and does not require a separately mailed original for a non-controlled drug.
- A pharmacist must decide whether a prescription is dispensable when the prescriber wrote a drug with two common dosage forms but did not specify which dosage form is intended. What action best preserves the validity of the order?
- Clarify the intended dosage form with the prescriber so the order is unambiguous
- Dispense whichever form is in stock
- Give the patient both forms to choose
- Substitute a different drug with one form
Correct answer: Clarify the intended dosage form with the prescriber so the order is unambiguous
The pharmacist should clarify the intended dosage form with the prescriber so the order unambiguously specifies what to dispense. Defaulting to whatever is in stock, handing over both forms, or substituting a different drug would each dispense on an unresolved ambiguity.
- A pharmacist evaluates whether a quantity written on a prescription is part of a valid, complete order. Why is the quantity to be dispensed treated as a required prescription element?
- It tells the patient how much to take per dose
- It sets the drug's shelf life
- It defines how much medication the pharmacist is authorized to provide on that order
- It establishes the pharmacy's wholesale cost
Correct answer: It defines how much medication the pharmacist is authorized to provide on that order
The quantity is a required element because it defines how much medication the pharmacist is authorized to dispense for that prescription. The per-dose amount is conveyed by the directions, not the quantity, and the quantity does not set shelf life or wholesale cost.
- A prescription is presented with the patient's name and a drug, but the directions for use simply read 'use.' Considering the requirement for adequate directions, what is the most appropriate determination?
- The single word 'use' is adequate as directions
- The directions are inadequate and must be clarified so the label can properly instruct the patient
- Directions are optional on any prescription
- The pharmacist may invent typical directions
Correct answer: The directions are inadequate and must be clarified so the label can properly instruct the patient
Adequate directions are required, and a vague single word is not adequate, so the pharmacist must clarify to label the medication properly. The word 'use' is not sufficient, directions are not optional, and the pharmacist should not invent directions rather than clarifying with the prescriber.
- A prescriber whose medical license has been suspended writes a prescription during the suspension. Regarding the validity of that prescription, what is the most accurate view?
- It is valid because the prescriber still has prescription pads
- It becomes valid once the pharmacy fills it
- It is valid if the patient is established
- A prescription written while the prescriber lacks current prescribing authority is not valid
Correct answer: A prescription written while the prescriber lacks current prescribing authority is not valid
A prescription written while the prescriber lacks current prescribing authority, such as during a license suspension, is not valid. Possessing prescription pads, having an established patient, or a pharmacy filling the order does not cure the absence of valid prescribing authority.
- A pharmacist wants to confirm that a prescriber actually holds the authority to prescribe a given controlled substance. Which characteristic of the prescriber's DEA registration most directly limits which controlled substances they may prescribe?
- The schedules the registration authorizes the prescriber to handle
- The registration's color
- The prescriber's office square footage
- The number of staff in the office
Correct answer: The schedules the registration authorizes the prescriber to handle
A DEA registration authorizes specific controlled-substance schedules, which directly limits which controlled substances the prescriber may prescribe. Office size, staff count, and the registration's color have no bearing on the schedules a prescriber is authorized to handle.
- A podiatrist presents a prescription for a medication intended to treat a foot condition. How does prescriber scope of practice bear on whether the pharmacist may fill it?
- A podiatrist may prescribe for any organ system
- Podiatrists may not write prescriptions
- The order falls within a podiatrist's recognized scope when it relates to conditions of the foot
- The pharmacy assigns the podiatrist's scope
Correct answer: The order falls within a podiatrist's recognized scope when it relates to conditions of the foot
A podiatrist's prescribing authority is recognized for conditions within their scope, such as those affecting the foot, so a foot-related order falls within that scope. Podiatrists may write prescriptions, are not authorized for every organ system, and the pharmacy does not define a prescriber's scope of practice.
- A pharmacist confirms that a prescriber's DEA registration has expired and was not renewed. The prescriber presents a controlled-substance order dated after the expiration. What is the correct conclusion about prescriber authority?
- Expiration does not affect prescribing authority
- Without a current valid DEA registration, the prescriber lacks federal authority to issue that controlled-substance order
- The pharmacy can renew the registration on the prescriber's behalf
- The order is fine because the prescriber once held a registration
Correct answer: Without a current valid DEA registration, the prescriber lacks federal authority to issue that controlled-substance order
A controlled-substance order requires a current valid DEA registration, so an expired, unrenewed registration means the prescriber lacks federal authority to issue it. Expiration does affect authority, the pharmacy cannot renew the prescriber's registration, and prior registration does not validate an order written after it lapsed.
- A physician assistant presents a controlled-substance prescription. What two-part determination establishes whether the physician assistant is authorized to issue it?
- Whether the patient likes the physician assistant and pays cash
- Whether the physician assistant wears a white coat and uses a printed form
- Whether the supervising physician is in the building and the office is large
- Whether the physician assistant has state-granted prescriptive authority for that drug class and a valid DEA registration
Correct answer: Whether the physician assistant has state-granted prescriptive authority for that drug class and a valid DEA registration
Authority for a physician assistant to prescribe a controlled substance turns on state-granted prescriptive authority for that drug class together with a valid DEA registration. Patient preference, payment method, attire, the form's appearance, and the supervisor's physical presence do not establish that prescribing authority.
- A pharmacist receives a prescription from an out-of-state prescriber for a non-controlled drug. What is the pharmacist's main authority-related responsibility before filling it?
- To confirm the prescriber is acting within lawful prescribing authority, recognizing such orders can generally be filled
- To reject it solely because the prescriber is out of state
- To require the prescriber to relocate
- To convert it to an in-state prescriber's name
Correct answer: To confirm the prescriber is acting within lawful prescribing authority, recognizing such orders can generally be filled
The pharmacist's main responsibility is to confirm the out-of-state prescriber is acting within lawful authority, since such non-controlled orders can generally be filled. Rejecting solely for being out of state, demanding relocation, or substituting an in-state prescriber's name are not appropriate responses.
- A pharmacist receives a controlled-substance prescription where the DEA number's check-digit pattern does not validate. What does an invalid DEA number pattern most directly suggest the pharmacist should do?
- Dispense immediately to avoid delay
- Add a digit to make the number validate
- Treat it as a warning sign and verify the prescriber's registration and authority before dispensing
- Substitute the patient's identification number
Correct answer: Treat it as a warning sign and verify the prescriber's registration and authority before dispensing
An invalid DEA number pattern is a warning sign, so the pharmacist should verify the prescriber's registration and authority before dispensing. Dispensing immediately, altering the number to make it validate, or substituting the patient's identification number would all bypass that verification of authority.
- A pharmacist must articulate the difference between a prescriber's professional license and a DEA registration. Which statement best captures the distinct role of the DEA registration?
- It replaces the need for a professional license
- It grants federal authorization to handle and prescribe controlled substances, separate from the underlying professional license
- It is required for all non-controlled prescriptions
- It certifies the prescriber's billing privileges
Correct answer: It grants federal authorization to handle and prescribe controlled substances, separate from the underlying professional license
A DEA registration provides federal authorization to handle and prescribe controlled substances, distinct from the professional license that establishes the right to practice. It does not replace the professional license, is not required for non-controlled prescriptions, and does not certify billing privileges.
- A pharmacist describes why a Schedule II prescription carries the strictest controls among the schedules. What underlying characteristic of Schedule II drugs drives those stricter dispensing requirements?
- They have no accepted medical use
- They are only available by mail
- They are always more expensive
- They have a high potential for abuse while having accepted medical uses
Correct answer: They have a high potential for abuse while having accepted medical uses
Schedule II drugs have a high abuse potential while still having accepted medical uses, which drives the stricter dispensing controls placed on them. Lacking accepted medical use describes Schedule I, while cost and mail-only availability are not the basis for Schedule II's stricter requirements.
- A prescriber transmits a Schedule II prescription electronically through a certified electronic prescribing application. Beyond the usual prescription elements, what feature distinguishes a compliant electronic Schedule II order?
- Use of a system meeting the controlled-substance e-prescribing security and authentication requirements
- A patient-entered personal identification number
- A scanned image of the prescriber's office sign
- Inclusion of the pharmacy's loyalty program number
Correct answer: Use of a system meeting the controlled-substance e-prescribing security and authentication requirements
A compliant electronic Schedule II order must originate from a system that meets the controlled-substance e-prescribing security and authentication requirements. A patient-entered PIN, a scanned office sign, and a loyalty program number do not satisfy those electronic prescribing safeguards.
- A pharmacist receives a written Schedule II prescription that lacks the patient's address but contains everything else. Compared with the more flexible handling of routine non-controlled orders, how should the pharmacist approach this missing element on a Schedule II?
- Ignore it because address is never required
- Have the patient write in any address
- Resolve the missing information appropriate to a Schedule II order before dispensing, given the heightened requirements
- Dispense and add the address from memory
Correct answer: Resolve the missing information appropriate to a Schedule II order before dispensing, given the heightened requirements
Given the heightened requirements for Schedule II, the pharmacist should resolve the missing patient information appropriately before dispensing rather than dispensing on an incomplete controlled order. Ignoring the omission, letting the patient write in any address, or filling in an address from memory would not properly cure the deficiency on a Schedule II prescription.
- A pharmacy receives a faxed Schedule II prescription for a patient enrolled in a hospice program. How does this situation relate to the general rule that Schedule II requires a written original?
- Hospice patients may never receive Schedule II drugs
- A recognized exception allows a faxed Schedule II to serve as the original for certain situations such as hospice patients
- All faxed Schedule II orders are valid for any patient
- The fax must always be replaced by an oral order
Correct answer: A recognized exception allows a faxed Schedule II to serve as the original for certain situations such as hospice patients
There is a recognized exception under which a faxed Schedule II prescription may serve as the original for certain situations, including patients in a hospice program. Hospice patients may receive Schedule II drugs, faxed Schedule II orders are not universally valid for any patient, and the fax need not be replaced by an oral order in these recognized exceptions.
- A prescriber wishes to provide a stable Schedule II patient up to a 90-day supply using a series of prescriptions written on the same day. What condition must accompany those multiple prescriptions to comply with Schedule II rules?
- Each must be filled on the same day
- Each must authorize unlimited refills
- Each must be signed by a different prescriber
- Each subsequent prescription notes the earliest date it may be filled
Correct answer: Each subsequent prescription notes the earliest date it may be filled
When multiple same-day Schedule II prescriptions are used for a future supply, each subsequent one must note the earliest date it may be filled. They do not carry refills, need not be signed by different prescribers, and are intentionally not all filled on the same day.
- A pharmacy technician asks whether a Schedule II prescription that has been on file unfilled for several weeks can still be dispensed. What general principle should guide the pharmacist's answer?
- The pharmacist should consider whether too much time has passed for the order to still reflect the patient's current legitimate need
- Schedule II prescriptions never expire and can be filled anytime
- Only the technician can decide
- It can be filled with refills added to compensate
Correct answer: The pharmacist should consider whether too much time has passed for the order to still reflect the patient's current legitimate need
The pharmacist should consider whether the elapsed time means the Schedule II order no longer reflects the patient's current legitimate need before dispensing it. Schedule II prescriptions are not appropriately filled at any time without regard to staleness, refills cannot be added, and the judgment belongs to the pharmacist rather than the technician.
- A pharmacist explains to a new graduate why a Schedule II prescription cannot simply be phoned in by the prescriber for routine outpatient use. What is the core reason?
- Phones are unreliable
- Phoning costs the prescriber money
- Routine oral prescriptions are not permitted for Schedule II, which requires a valid signed order
- The patient cannot hear the order
Correct answer: Routine oral prescriptions are not permitted for Schedule II, which requires a valid signed order
The core reason is that routine oral prescriptions are not permitted for Schedule II drugs, which require a valid signed order for routine outpatient dispensing. Phone reliability, prescriber cost, and patient hearing are not the basis for prohibiting routine oral Schedule II orders.
- A pharmacist receives a Schedule II prescription on which the prescriber wrote a quantity in numerals only. Considering safeguards against alteration, what practice strengthens a Schedule II order against tampering?
- Leaving wide blank spaces after the quantity
- Writing the quantity in both numerals and words
- Using only abbreviations
- Omitting the date to reduce clutter
Correct answer: Writing the quantity in both numerals and words
Writing the quantity in both numerals and words strengthens a Schedule II order against tampering by making alteration harder. Leaving wide blank spaces invites alteration, abbreviations create ambiguity, and omitting the date removes a required element rather than improving security.
- A prescriber telephones an emergency oral authorization for a Schedule II drug to a patient in genuine immediate need. What is the maximum quantity the pharmacist may dispense under this emergency authorization?
- A full month's supply automatically
- Enough for the entire course of therapy
- Twice the amount the patient requests
- Only the amount adequate to cover the emergency period
Correct answer: Only the amount adequate to cover the emergency period
Under an emergency oral Schedule II authorization, the pharmacist may dispense only the amount adequate to cover the emergency period. A full month's supply, double the requested amount, and the entire course of therapy all exceed the emergency-quantity limitation.
- During an emergency Schedule II oral order, the pharmacist immediately reduces the prescriber's spoken instructions to writing. Why is reducing the oral order to writing at that moment important?
- It creates the contemporaneous written record required for the emergency dispensing
- It speeds up insurance billing
- It eliminates the need for any follow-up prescription
- It allows refills to be added
Correct answer: It creates the contemporaneous written record required for the emergency dispensing
Reducing the oral order to writing immediately creates the contemporaneous written record required for emergency Schedule II dispensing. It is not done to speed billing, does not eliminate the required follow-up written prescription, and does not enable refills, which are never allowed for Schedule II.
- After an emergency oral Schedule II dispensing, the prescriber delivers the cover written prescription on day five. Given the federal follow-up requirement, how should the pharmacist regard this timing?
- It is timely because a week is allowed
- It is irrelevant because the drug is already dispensed
- It is late, since the written prescription was required within 72 hours, and the failure must be addressed
- It extends the emergency authorization automatically
Correct answer: It is timely because a week is allowed
Under current federal rules the prescriber must deliver the written cover prescription within seven days of the emergency oral order, so delivery on day five is timely. The timing is not irrelevant simply because the drug was dispensed, the window is not seventy-two hours, and late delivery would not extend the emergency authorization.
- A covering pharmacist receives an emergency Schedule II oral authorization from a prescriber the pharmacist cannot immediately confirm. What good-faith step is most appropriate before dispensing under the emergency provision?
- Skip verification because emergencies waive it
- Make a reasonable effort to verify the caller is the genuine, authorized prescriber
- Ask the patient to confirm the prescriber's number
- Dispense double in case the order is real
Correct answer: Make a reasonable effort to verify the caller is the genuine, authorized prescriber
Even in an emergency, the pharmacist should make a reasonable good-faith effort to verify the caller is the genuine authorized prescriber. Emergencies do not waive verification, relying on the patient to confirm the prescriber's number is inadequate, and dispensing extra quantity is not appropriate.
- A pharmacist considers when the emergency Schedule II oral provision may even be used. Which scenario best fits the threshold for invoking it?
- The prescriber's office is closed for lunch
- The pharmacy is short-staffed
- The patient wants to avoid a second trip
- Immediate administration is medically necessary, no suitable alternative exists, and a written prescription cannot reasonably be provided first
Correct answer: Immediate administration is medically necessary, no suitable alternative exists, and a written prescription cannot reasonably be provided first
The emergency provision applies when immediate administration is medically necessary, no suitable alternative exists, and a written prescription cannot reasonably be provided beforehand. A lunch closure, patient convenience, and pharmacy staffing do not meet the emergency threshold.
- After an emergency Schedule II oral dispensing, the prescriber fails to deliver the required written prescription within the allotted time. What duty does this trigger for the pharmacist?
- To notify the DEA of the prescriber's failure to furnish the written prescription
- No duty arises
- To re-dispense the drug as a refill
- To bill the prescriber for the inconvenience
Correct answer: To notify the DEA of the prescriber's failure to furnish the written prescription
The pharmacist must notify the DEA when the prescriber fails to furnish the required written prescription within the allotted time. A duty does arise, the drug cannot be re-dispensed as a refill, and billing the prescriber is not the required action.
- A pharmacist notes that the emergency Schedule II provision is the narrow exception to a broader rule. What broader rule does this exception carve out from?
- The rule that Schedule II prescriptions cannot be refilled
- The rule requiring child-resistant packaging
- The rule that a routine Schedule II prescription must be a valid signed order, not an oral one
- The rule on biennial inventory
Correct answer: The rule that a routine Schedule II prescription must be a valid signed order, not an oral one
The emergency oral provision is a narrow exception to the broader rule that routine Schedule II prescriptions must be valid signed orders rather than oral ones. The no-refill rule, child-resistant packaging, and biennial inventory are separate requirements that the emergency oral provision does not carve out.
- A pharmacist fills a new Schedule III prescription that authorizes three refills. How long after the issue date do those authorized refills remain valid?
- Indefinitely until used
- For up to six months from the date of issuance
- For exactly one year
- Only until the end of the calendar month
Correct answer: For up to six months from the date of issuance
Authorized refills on a Schedule III prescription remain valid for up to six months from the date of issuance. They do not last indefinitely, do not extend to a full year, and are not limited merely to the end of the calendar month.
- A patient has a Schedule IV prescription authorizing five refills, and after using two refills the six-month window from the issue date expires with three refills remaining. What is the correct handling of the remaining refills?
- Dispense them because refills were authorized
- Extend the window because refills remain
- Dispense them only with a doubled quantity
- They are no longer valid once six months have elapsed, so a new prescription is required
Correct answer: They are no longer valid once six months have elapsed, so a new prescription is required
Once six months elapse from the issue date, remaining refills on a Schedule III through V prescription are no longer valid and a new prescription is required. Remaining authorization does not override the time limit, the window is not extended by leftover refills, and doubling the quantity is not a remedy.
- A pharmacist compares the refill limits across the controlled schedules to a colleague. Which statement correctly summarizes the federal refill limit for Schedule III through V drugs?
- Up to five refills within six months of the issue date, if authorized
- No refills are permitted at all
- Up to twelve refills within one year
- Unlimited refills with prescriber notation
Correct answer: Up to five refills within six months of the issue date, if authorized
Schedule III through V prescriptions may be refilled up to five times within six months of the issue date when authorized. No refills at all describes Schedule II, while twelve refills in a year and unlimited refills both exceed the federal limit.
- A prescriber writes 'refills: 6' on a new Schedule IV prescription. How should the pharmacist treat the authorization that exceeds the federal cap?
- Allow all six because the prescriber authorized them
- Allow six within one year instead
- Limit refilling to the federal maximum of five within six months despite the larger number written
- Refuse to fill the prescription at all
Correct answer: Limit refilling to the federal maximum of five within six months despite the larger number written
Even when the prescriber writes more, refilling a Schedule III through V drug is limited to the federal maximum of five within six months. The pharmacist cannot honor six refills, cannot convert it to six within a year, and need not refuse the prescription entirely since it can still be filled within the legal limit.
- A pharmacy's system shows a Schedule V prescription with one refill used and four remaining, all within the six-month window, but the patient is requesting it well before the previous supply should be exhausted. Beyond confirming refills remain, what should the pharmacist also assess?
- Only the wholesaler's price
- Whether the early request is consistent with appropriate use, since remaining refills alone do not justify early dispensing
- The cashier's schedule
- The store's foot traffic
Correct answer: Whether the early request is consistent with appropriate use, since remaining refills alone do not justify early dispensing
The pharmacist should also assess whether the early request fits appropriate use, because available refills alone do not justify premature dispensing of a controlled substance. Wholesaler price, cashier schedule, and store foot traffic are irrelevant to the appropriateness of an early controlled refill.
- A pharmacist must explain why Schedule II and the lower controlled schedules differ on refills. Which contrast is accurate?
- Schedule II permits five refills while Schedule III permits none
- Schedule V permits unlimited refills while Schedule III permits none
- All controlled schedules permit the same number of refills
- Schedule II permits no refills, while Schedule III through V permit up to five refills within six months
Correct answer: Schedule II permits no refills, while Schedule III through V permit up to five refills within six months
Schedule II prescriptions carry no refills, whereas Schedule III through V prescriptions may be refilled up to five times within six months. The other options reverse the schedules, claim uniform limits, or wrongly distinguish Schedule V from Schedule III, which share the same refill cap.
- A patient picking up a new prescription is offered a discussion of the medication by the pharmacist. The legal expectation to provide this offer traces to a federal law affecting Medicaid patients. What did that law require pharmacists to do?
- Offer to counsel patients receiving prescriptions
- Charge for each counseling session
- Refuse to dispense without a written exam
- Report patient diagnoses to the state
Correct answer: Offer to counsel patients receiving prescriptions
The federal law, OBRA 90, required pharmacists to offer to counsel patients receiving prescriptions, originally for Medicaid recipients and widely extended by states. It did not require charging for counseling, conditioning dispensing on a written exam, or reporting patient diagnoses.
- A pharmacist preparing to counsel a patient on a new inhaler wants to cover the most clinically useful information. Which set of topics best fits the purpose of patient counseling?
- The pharmacy's hours and parking
- The wholesaler's delivery route
- Proper inhaler technique, expected effects, and what to do if a dose is missed
- The store's rewards program tiers
Correct answer: Proper inhaler technique, expected effects, and what to do if a dose is missed
Counseling should cover clinically useful information such as proper technique, expected effects, and missed-dose guidance to support safe use. Store hours, the wholesaler's route, and rewards tiers do not help the patient use the inhaler safely.
- A pharmacist wonders at what point the offer to counsel is most meaningful for a patient receiving a new medication. When is the counseling offer best extended?
- After the medication course is complete
- At or before the time the prescription is provided to the patient
- Only at the patient's next annual visit
- Only if the patient telephones later
Correct answer: At or before the time the prescription is provided to the patient
The counseling offer is most meaningful at or before the time the prescription is provided, when the information can guide proper use. Offering it after the course is complete, only at a yearly visit, or only if the patient calls later defeats the timely purpose of the offer.
- A patient receives medication through the pharmacy's mail service and is never physically present at the counter. How can the counseling-offer obligation be satisfied in this setting?
- By waiving counseling entirely for mail patients
- By referring the patient to a general search engine
- By having the courier explain the medication
- By providing written information and a way to reach a pharmacist, such as a toll-free number
Correct answer: By providing written information and a way to reach a pharmacist, such as a toll-free number
For mail-service patients, the obligation can be met by supplying written information plus a means to reach a pharmacist, such as a toll-free telephone line. Waiving counseling, relying on a courier, or referring patients to a search engine does not satisfy the counseling-offer requirement.
- A pharmacist counsels a patient who is starting a medication with important administration instructions. To verify the patient can act correctly, which counseling approach is most effective?
- Asking the patient to restate how and when they will take the medication
- Reading the leaflet aloud word for word and leaving
- Telling the patient to ask a friend
- Limiting the discussion to the price
Correct answer: Asking the patient to restate how and when they will take the medication
Asking the patient to restate how and when they will take the medication verifies understanding and lets the pharmacist correct misunderstandings. Reading a leaflet and leaving, deferring to a friend, and discussing only price do not confirm the patient grasps the instructions.
- A new pharmacist asks whether the duty to counsel applies only to brand-new prescriptions. How does the counseling expectation generally extend beyond a first fill?
- It never applies to anything but the first fill
- It applies only to controlled substances
- An offer to counsel and chance to address questions remains appropriate on refills, especially with new concerns or therapy changes
- It applies only to pediatric patients
Correct answer: An offer to counsel and chance to address questions remains appropriate on refills, especially with new concerns or therapy changes
Counseling and the opportunity to address questions remain appropriate on refills, particularly when there are new concerns or therapy changes. The duty is not limited to first fills, controlled substances only, or pediatric patients only.
- A pharmacist who has just made an offer to counsel a patient wants to be sure the pharmacy can later show it met its obligation. What documentation practice best demonstrates that the offer was made?
- Keeping no record because counseling is spoken
- Recording that the offer was extended and whether it was accepted or declined where required
- Logging only the time the store opened
- Noting the patient's vehicle
Correct answer: Recording that the offer was extended and whether it was accepted or declined where required
Recording that the offer was extended and whether it was accepted or declined demonstrates the pharmacy met its counseling-offer obligation. Keeping no record, logging the store's opening time, or noting the patient's vehicle does not document the counseling offer.
- A pharmacy uses a pickup signature pad with a checkbox indicating that counseling was offered and either accepted or declined. What is the primary purpose of that checkbox?
- To market new products to the patient
- To rank employees by speed
- To track the patient's spending habits
- To create a record supporting compliance with the counseling-offer requirement
Correct answer: To create a record supporting compliance with the counseling-offer requirement
The checkbox's primary purpose is to create a record supporting compliance with the counseling-offer requirement. Marketing products, tracking spending, and ranking employees by speed are not the reason the counseling-offer field exists.
- A board inspector reviews how a pharmacy proves it consistently offers counseling. Which record set best supports that the offer is being made over time?
- Documentation showing counseling offers and the acceptance or refusal where required
- Only the daily cash totals
- Only the employee parking assignments
- Only the thermostat logs
Correct answer: Documentation showing counseling offers and the acceptance or refusal where required
Records showing counseling offers and their acceptance or refusal best support that the offer is being made consistently. Cash totals, parking assignments, and thermostat logs do not evidence the counseling-offer practice.
- A patient declines counseling at pickup. Considering documentation, what is the appropriate handling of that refusal?
- Refuse to release the prescription
- Report the patient to the licensing board
- Document that the offer was made and that the patient declined where required
- Make no note at all
Correct answer: Document that the offer was made and that the patient declined where required
When a patient declines, the pharmacy should document that the offer was made and that the patient declined, supporting compliance. Withholding the prescription, reporting the patient for declining, and leaving the interaction undocumented are all inappropriate.
- A pharmacist reflects on why documenting the counseling offer matters even when no harm occurs. What is the central benefit of maintaining this documentation?
- It increases prescription sales
- It provides evidence that the safe-use opportunity was offered, supporting compliance and patient safety
- It shortens the patient's wait time
- It eliminates the need to actually counsel
Correct answer: It provides evidence that the safe-use opportunity was offered, supporting compliance and patient safety
Documenting the offer provides evidence that the safe-use opportunity was extended, supporting both compliance and patient safety. It does not boost sales, shorten wait times, or remove the need to actually counsel when accepted.
- A pharmacy is choosing how to capture counseling-offer documentation across many daily pickups efficiently. Which method most directly serves the documentation goal without compromising it?
- A sign assuming all patients were counseled
- Relying on each pharmacist's memory at month end
- A monthly estimate of how many offers were probably made
- An electronic prompt that records the offer and the patient's acceptance or refusal
Correct answer: An electronic prompt that records the offer and the patient's acceptance or refusal
An electronic prompt that records the offer and the patient's response directly serves the documentation goal at scale. Relying on memory, monthly estimates, or an assumption sign does not create reliable records that the offer was made.
- A pharmacist must explain the general rule governing how patient prescription records are shared. Under the federal privacy framework, individually identifiable health information held by the pharmacy is generally treated how?
- As protected information that may be used or disclosed only as permitted
- As public records open to anyone
- As marketing data the pharmacy may sell
- As the prescriber's sole property
Correct answer: As protected information that may be used or disclosed only as permitted
Individually identifiable health information is protected and may be used or disclosed only as permitted under the privacy framework. It is not public, not freely sellable marketing data, and not the prescriber's sole property.
- A pharmacist needs to fax a patient's prescription information to the patient's physician to coordinate care. Under patient privacy rules, how is this disclosure best characterized?
- A prohibited disclosure requiring a court order
- A marketing disclosure requiring patient payment
- A permitted disclosure for treatment purposes
- A research disclosure requiring federal approval
Correct answer: A permitted disclosure for treatment purposes
Sharing prescription information with the patient's physician to coordinate care is a permitted disclosure for treatment purposes. It is not a prohibited disclosure needing a court order, a marketing disclosure, or a research disclosure requiring federal approval.
- A pharmacy wants to reduce the chance that patients overhear each other's protected information while waiting. Which counter-area design choice best supports confidentiality?
- A single open window where everyone lines up close together
- A designated private or semi-private consultation area away from the waiting line
- A speaker that announces each patient's medication
- A public screen listing names and drugs
Correct answer: A designated private or semi-private consultation area away from the waiting line
A designated private or semi-private consultation area away from the waiting line reduces the risk that protected information is overheard. A crowded single window, a medication-announcing speaker, and a public name-and-drug screen all increase improper disclosure.
- A spouse who is not the patient's authorized representative asks the pharmacist what medications an adult patient is taking. Under confidentiality rules, what is the appropriate response?
- Share the full list because they are married
- Disclose if the spouse seems trustworthy
- Disclose only the drug names
- Avoid disclosing protected information without the patient's authorization or another permitted basis
Correct answer: Avoid disclosing protected information without the patient's authorization or another permitted basis
Without the patient's authorization or another permitted basis, the pharmacist should avoid disclosing protected information to a spouse who is not an authorized representative. Marriage alone, partial disclosure of drug names, and the spouse seeming trustworthy do not justify the disclosure.
- A pharmacy's electronic patient profiles must be safeguarded against improper access. Which control most directly protects the confidentiality of those electronic records?
- Assigning individual logins and limiting access to authorized personnel
- Sharing one password among all staff
- Posting the system password near the terminal
- Letting patients log in to browse profiles
Correct answer: Assigning individual logins and limiting access to authorized personnel
Assigning individual logins and limiting access to authorized personnel directly protects the confidentiality of electronic patient records. Shared passwords, posting the password, and allowing patients to browse profiles all undermine that protection.
- A patient requests a copy of their own medication history from the pharmacy. Under the privacy framework, how should the pharmacist generally treat this request?
- Deny it because records belong only to the pharmacy
- Provide it only to the patient's employer
- Provide the patient access to their own protected information following applicable procedures
- Require a subpoena in every instance
Correct answer: Provide the patient access to their own protected information following applicable procedures
Patients generally have a right to access their own protected information, so the pharmacist should provide it following applicable procedures. The records are not the pharmacy's alone to withhold, providing them to the employer instead is improper, and a subpoena is not required for the patient's own information.
- A pharmacy discovers that a stack of old prescription printouts containing patient names and medications was thrown in the regular trash intact. Regarding confidentiality, what does proper handling of such records require?
- Nothing, since the records are old
- Disposing of records with patient information in a manner that renders them unreadable, such as shredding
- Recycling them with names visible
- Selling them to a recycler
Correct answer: Disposing of records with patient information in a manner that renders them unreadable, such as shredding
Records containing patient information must be disposed of in a way that renders them unreadable, such as shredding, to protect confidentiality. Treating old records as exempt, recycling them with names visible, or selling them intact all risk improper disclosure of protected information.
- A market research company offers to pay the pharmacy for a list of patients on a specific medication to promote a competitor's product. Under patient confidentiality rules, what is the correct response?
- Sell the list because it is profitable
- Provide the list if a contract is signed
- Provide initials only
- Decline, since disclosing protected information for unauthorized marketing is not permitted without proper authorization
Correct answer: Decline, since disclosing protected information for unauthorized marketing is not permitted without proper authorization
Disclosing protected information for unauthorized marketing is not permitted without proper authorization, so the pharmacist should decline. Selling the list, sharing initials, or signing a contract to release it would all be improper disclosures.
- A patient brings back an unopened, sealed bottle of a non-controlled tablet that they took home last week and now no longer need, asking the pharmacy to restock and reuse it. What is the general rule the pharmacist should follow?
- Do not return it to dispensing stock for another patient, because its storage after leaving the pharmacy cannot be assured
- Restock and reuse it because the seal is intact
- Reuse it only if the patient is a regular customer
- Reuse it after checking the expiration date
Correct answer: Do not return it to dispensing stock for another patient, because its storage after leaving the pharmacy cannot be assured
A medication that left the pharmacy's control should not be returned to dispensing stock for another patient because its storage can no longer be assured. An intact seal, regular-customer status, and a valid expiration date do not overcome the loss of control once the product left the pharmacy.
- A pharmacist must articulate the principal reason dispensed medications generally cannot be redispensed to other patients. What is that reason?
- It would lower store profits
- It would upset the wholesaler
- Once the product leaves the pharmacy's control, its integrity and storage can no longer be assured, creating a patient-safety risk
- It conflicts with advertising rules
Correct answer: Once the product leaves the pharmacy's control, its integrity and storage can no longer be assured, creating a patient-safety risk
The principal reason is patient safety: once a product leaves the pharmacy's control, its integrity and storage cannot be assured. Lower profits, wholesaler relations, and advertising rules are not the basis for prohibiting redispensing of returned medication.
- A long-term care facility returns sealed unit-dose packages that remained within a secure, controlled distribution chain. Compared with an ordinary retail return, how may these be treated?
- They are always barred just like retail returns
- They may be eligible for reuse where the rules permit because integrity within the secure chain was maintained
- They may be freely sold to the public as new
- They must be discarded only if opened
Correct answer: They may be eligible for reuse where the rules permit because integrity within the secure chain was maintained
Sealed unit-dose returns kept within a secure controlled chain may be eligible for reuse where the rules permit, unlike ordinary retail returns whose integrity cannot be assured. They are not always barred, are not sold to the public as new, and the eligibility is not defined by simply being unopened in a retail context.
- A patient wants to return an unused controlled substance to the pharmacy. Compared with a non-controlled return, what additional consideration governs taking back a controlled substance?
- There is no difference from a non-controlled return
- It may be casually resold like any product
- It must be immediately redispensed to the next patient
- It is subject to additional handling and disposal rules and generally cannot be returned to stock for reuse
Correct answer: It is subject to additional handling and disposal rules and generally cannot be returned to stock for reuse
Taking back a controlled substance triggers additional handling and disposal rules, and such returns generally cannot go back into stock for reuse. There is a difference from non-controlled returns, immediate redispensing is not allowed, and casual resale is improper.
- A patient asks the pharmacy to take back several bottles of medications they no longer need so they can be disposed of safely. Rather than restocking them, what is the appropriate path?
- Direct the medications to an approved disposal or take-back method
- Restock the bottles for the next customer
- Repackage them as samples
- Resell them at a reduced price
Correct answer: Direct the medications to an approved disposal or take-back method
Unwanted dispensed medications should be directed to an approved disposal or take-back method rather than restocked. Restocking, repackaging as samples, or reselling them returns medication of unknown integrity to use.
- A pharmacy realizes it dispensed the wrong strength and the patient hands the unopened, incorrect product back at the counter before leaving the immediate area. How may the pharmacy handle this correction?
- It must treat the product as fully out of its control and never adjust the error
- Only the prescriber can fix a dispensing error
- Because the pharmacy is correcting its own error before the product entered uncontrolled use, it may resolve the mistake under its error-handling procedures
- The patient must keep the wrong strength
Correct answer: Because the pharmacy is correcting its own error before the product entered uncontrolled use, it may resolve the mistake under its error-handling procedures
When the pharmacy corrects its own dispensing error at the counter before the product enters uncontrolled use, it may resolve the mistake under its error-handling procedures. The pharmacy is not barred from correcting its own error, the fix is not limited to the prescriber, and the patient is not forced to keep the wrong product.
- A patient returns a partially used liquid antibiotic, asking for credit and reuse for someone else. Considering the integrity of a previously dispensed, opened product, what should the pharmacist do?
- Reuse it for the next patient since antibiotics are stable
- Decline to return it to stock for reuse, since a dispensed, used product cannot be redispensed to another patient
- Reuse it if the patient signs a waiver
- Reuse it after refrigerating it overnight
Correct answer: Decline to return it to stock for reuse, since a dispensed, used product cannot be redispensed to another patient
A dispensed, opened, partially used product cannot be returned to stock and redispensed to another patient, so the pharmacist should decline. Assumptions about stability, a patient waiver, and overnight refrigeration do not overcome the prohibition on redispensing a used product.
- A pharmacist reviews a prescription whose written quantity and the directions plus intended duration of therapy do not reconcile with one another. Before treating the order as complete, what should the pharmacist do?
- Dispense the lower of the two implied quantities
- Let the patient pick a quantity
- Average the two figures
- Resolve the inconsistency, typically by clarifying with the prescriber
Correct answer: Resolve the inconsistency, typically by clarifying with the prescriber
An internal inconsistency between quantity and directions should be resolved, usually by clarifying with the prescriber, before the order is treated as complete and valid. Dispensing the lower implied amount, averaging the figures, or letting the patient choose leaves the validity question unresolved.
- A pharmacist receives a prescription written by a prescriber acting within their scope, where the patient is the prescriber's own family member. Regarding validity for a non-controlled drug, what is the key requirement?
- The order must still be for a legitimate medical purpose with the required elements
- Family members can never receive valid prescriptions
- Such orders are automatically invalid
- The pharmacy must add a second prescriber
Correct answer: The order must still be for a legitimate medical purpose with the required elements
A prescription for a prescriber's family member must still be for a legitimate medical purpose and contain the required elements to be valid. Family relationships do not automatically invalidate an order, and the pharmacy does not need to add a second prescriber.
- A prescriber's authorized agent telephones a new non-controlled prescription to the pharmacy. What makes this oral order from an agent a valid prescription?
- Any caller may relay a prescriber's order
- The patient must also call to confirm
- The agent is acting with the prescriber's authority and the order contains the required elements
- The pharmacy supplies the authorization
Correct answer: The agent is acting with the prescriber's authority and the order contains the required elements
An oral non-controlled order relayed by the prescriber's authorized agent is valid when the agent acts with the prescriber's authority and the order has the required elements. Not just any caller may relay it, a confirming call from the patient is not the basis of validity, and the pharmacy does not supply the prescriber's authorization.
- A pharmacist questions whether a presented controlled-substance prescription truly originated from the named prescriber. What does verifying prescriber authority require here?
- Assuming it is genuine to avoid delay
- Taking reasonable steps to confirm the order genuinely came from an authorized prescriber acting within their authority
- Letting the patient vouch for the prescriber
- Dispensing first and verifying only if problems arise
Correct answer: Taking reasonable steps to confirm the order genuinely came from an authorized prescriber acting within their authority
When authenticity is in doubt, the pharmacist must take reasonable steps to confirm the order came from an authorized prescriber acting within their authority. Assuming genuineness, relying on the patient to vouch, or dispensing first and verifying later all skip required verification.
- A pharmacist must summarize, in one statement, what makes a prescription valid at the threshold. Which captures the foundational standard?
- It is valid if any drug name appears on it
- It is valid if it is electronically printed
- It is valid if the patient can pay for it
- It is issued for a legitimate medical purpose by an authorized prescriber and contains the required elements
Correct answer: It is issued for a legitimate medical purpose by an authorized prescriber and contains the required elements
A valid prescription is issued for a legitimate medical purpose by an authorized prescriber and contains the required elements. A drug name alone, the patient's ability to pay, and merely being printed electronically do not by themselves establish validity.
- A pharmacist explains why the date of issuance matters for refill limits on a Schedule IV prescription. What does the date of issuance specifically anchor for these refills?
- The start of the six-month period within which refills must occur
- The drug's manufactured expiration
- The patient's insurance year
- The wholesaler's reorder cycle
Correct answer: The start of the six-month period within which refills must occur
The date of issuance anchors the start of the six-month period within which Schedule III through V refills must occur. It does not set the drug's manufactured expiration, the insurance year, or the wholesaler's reorder cycle.
- A pharmacist receives a Schedule II prescription and a colleague asks how many times it can be refilled before a new order is needed. What is the accurate answer?
- Up to five times within six months
- Up to ten times within a year
- It cannot be refilled, so each fill requires its own valid prescription
- Once, then it expires
Correct answer: It cannot be refilled, so each fill requires its own valid prescription
A Schedule II prescription cannot be refilled, so each fill requires its own valid prescription. The five-in-six-months allowance belongs to Schedule III through V, and neither ten-in-a-year nor a single refill applies to Schedule II.
- A patient who declined counseling earlier returns later the same day with questions about a side effect. Given the documented refusal, how should the pharmacist respond?
- Refuse because the patient already declined
- Provide the counseling now and document it, since a prior refusal does not bar later counseling
- Charge a fee for changing their mind
- Refer the patient to the drug manufacturer
Correct answer: Provide the counseling now and document it, since a prior refusal does not bar later counseling
A prior documented refusal does not prevent later counseling, so the pharmacist should provide the counseling and document it. Refusing, charging a fee, or deflecting to the manufacturer would fail the patient and the counseling duty.
- A law enforcement officer arrives without legal process and asks the pharmacist to disclose a patient's medication records. Under patient privacy rules, how should the pharmacist generally proceed?
- Disclose everything immediately on request
- Disclose only the patient's address
- Refuse to acknowledge the patient under all circumstances
- Release information only as the privacy rules and applicable legal process permit
Correct answer: Release information only as the privacy rules and applicable legal process permit
The pharmacist should release information to law enforcement only as the privacy rules and applicable legal process permit, not freely on request. Disclosing everything immediately oversteps protections, a blanket refusal in every case ignores lawful process, and selectively disclosing an address is still an improper disclosure absent a permitted basis.
- A pharmacist annotating an emergency oral Schedule II order wants the records to clearly tie together once the written cover prescription arrives. How should the later written prescription relate to the original oral authorization?
- It should be connected to the earlier emergency oral authorization so records reflect the same dispensing
- It should be filed as a brand-new, unrelated order with refills
- It should be discarded as redundant
- It should be returned to the prescriber unfiled
Correct answer: It should be connected to the earlier emergency oral authorization so records reflect the same dispensing
The written cover prescription should be connected to the earlier emergency oral authorization so the records reflect the same emergency dispensing. Filing it as a new order with refills, discarding it, or returning it unfiled breaks the required link documenting the emergency event.
- A pharmacist must distinguish what a prescriber's professional scope of practice governs from what a DEA registration governs. Which pairing is correct?
- Scope of practice governs DEA schedules; DEA registration governs the patient's diagnosis
- Both govern only the prescription's appearance
- Scope of practice governs the conditions a prescriber may treat; DEA registration governs authority to prescribe controlled substances
- Neither affects whether an order is valid
Correct answer: Scope of practice governs the conditions a prescriber may treat; DEA registration governs authority to prescribe controlled substances
Scope of practice governs the conditions a prescriber may treat, while the DEA registration governs federal authority to prescribe controlled substances. Scope does not set DEA schedules, neither concept is about the prescription's appearance, and both clearly affect whether an order is valid.
- A pharmacist is asked whether a refill on a Schedule III prescription can be carried out after both the six-month window has closed and only three of five authorized refills were used. What is the correct determination?
- Allow it because refills remain
- Do not refill it, since the six-month limit has passed and a new prescription is required
- Allow it with a reduced quantity
- Reset the clock and continue refilling
Correct answer: Do not refill it, since the six-month limit has passed and a new prescription is required
Once the six-month limit passes, the pharmacist should not refill a Schedule III prescription even with authorized refills remaining, and a new prescription is required. Remaining refills do not extend the order, a reduced quantity is not a remedy, and the six-month clock does not reset.
- A pharmacist confirms that a presented prescription contains the patient name, drug, strength, directions, quantity, prescriber information, date, and authorization. What overall conclusion follows about these elements?
- The elements are decorative formalities
- The date and signature are optional extras
- Only the drug name actually matters
- Together these constitute the core required elements that make the order a valid, dispensable prescription
Correct answer: Together these constitute the core required elements that make the order a valid, dispensable prescription
Together the patient name, drug, strength, directions, quantity, prescriber information, date, and authorization constitute the core required elements of a valid, dispensable prescription. They are not decorative formalities, the drug name is not the only element that matters, and the date and signature are not optional extras.
- A federal standard requires that for a controlled substance prescription to be effective, it must be issued for a legitimate medical purpose. Whose conduct is being evaluated when this legitimacy standard is first applied at the point the order is written?
- The drug wholesaler shipping the product
- The pharmacy technician entering the order
- The individual practitioner issuing the prescription
- The patient's health insurer
Correct answer: The individual practitioner issuing the prescription
The legitimate medical purpose standard is first applied to the individual practitioner issuing the prescription, who must write it for a real medical need. A technician entering the order, a wholesaler shipping product, and an insurer paying the claim are not the parties whose prescribing conduct creates the legitimacy of the order.
- A practitioner writes controlled substance prescriptions for themselves and for office staff who have never been examined as patients. Why do these orders typically fail the legitimate medical purpose standard?
- Because controlled substances can never be prescribed to office staff
- Because office staff cannot legally take any medication
- Because the prescriptions were written on paper rather than electronically
- Because there is no genuine practitioner-patient relationship or individualized medical evaluation supporting the orders
Correct answer: Because there is no genuine practitioner-patient relationship or individualized medical evaluation supporting the orders
Self-prescribing and writing for un-examined staff fail the legitimate medical purpose standard because there is no genuine practitioner-patient relationship or individualized evaluation behind the orders. Office staff are not categorically barred from medication, the format of the prescription is irrelevant, and the staff are not prohibited from taking drugs generally.
- A pharmacist receives a controlled substance order from an out-of-state telemedicine prescriber for a patient the prescriber has only briefly contacted online. When evaluating legitimate medical purpose, what is the most appropriate pharmacist action?
- Automatically reject all telemedicine prescriptions
- Dispense without question because telemedicine is always valid
- Verify that a genuine evaluation and prescriber-patient relationship support the order before dispensing
- Refer the patient to a competing pharmacy to avoid the decision
Correct answer: Verify that a genuine evaluation and prescriber-patient relationship support the order before dispensing
The pharmacist should verify that a genuine evaluation and prescriber-patient relationship support the telemedicine order before dispensing, since legitimate medical purpose still applies. Telemedicine prescriptions are not categorically invalid or automatically valid, and shifting the patient elsewhere does not discharge the pharmacist's duty to assess legitimacy.
- A pharmacist concludes after investigation that a controlled substance prescription was not issued for a legitimate medical purpose. Analyzing the dispensing decision, what is the correct course of action?
- Dispense it anyway and let the prescriber take all responsibility
- Hold the prescription indefinitely without telling the patient
- Fill a reduced quantity as a compromise
- Decline to fill the prescription and document the basis for the refusal
Correct answer: Decline to fill the prescription and document the basis for the refusal
When a prescription lacks a legitimate medical purpose, the pharmacist should decline to fill it and document the basis for the refusal. Dispensing anyway exposes the pharmacist to liability, filling a reduced quantity still dispenses an illegitimate order, and silently holding it indefinitely fails to communicate or resolve the matter.
- Corresponding responsibility means the legal duty for the proper prescribing and dispensing of a controlled substance is shared. Between which two roles is this duty divided under federal regulation?
- The prescriber and the dispensing pharmacist
- The patient and the insurer
- The manufacturer and the distributor
- The board of pharmacy and the DEA
Correct answer: The prescriber and the dispensing pharmacist
Corresponding responsibility divides the duty for proper controlled substance handling between the prescriber who issues the order and the pharmacist who dispenses it. Patients and insurers, manufacturers and distributors, and regulatory agencies are not the parties who share this point-of-care dispensing duty.
- A new graduate pharmacist asks what corresponding responsibility means in plain terms. Which statement best summarizes the concept?
- The dispensing pharmacist shares an independent legal duty to ensure each controlled substance prescription is legitimate
- The pharmacist may rely entirely on the prescriber's judgment without independent review
- The pharmacist is responsible only for counting the correct number of tablets
- The duty applies only to non-controlled medications
Correct answer: The dispensing pharmacist shares an independent legal duty to ensure each controlled substance prescription is legitimate
Corresponding responsibility means the dispensing pharmacist shares an independent legal duty to ensure each controlled substance prescription is legitimate. The pharmacist cannot simply defer to the prescriber, the duty goes well beyond accurate counting, and it specifically concerns controlled substances rather than only non-controlled drugs.
- A pharmacist suspects a controlled substance prescription is not legitimate but fills it to avoid an argument with the patient. Under corresponding responsibility, how is this decision best characterized?
- A prudent customer-service choice with no legal downside
- An action protected because the patient insisted
- A matter solely for the prescriber to answer for
- A failure to exercise the pharmacist's corresponding responsibility duty that can lead to liability
Correct answer: A failure to exercise the pharmacist's corresponding responsibility duty that can lead to liability
Dispensing a suspected illegitimate prescription to avoid conflict is a failure of corresponding responsibility that can lead to liability for the pharmacist. It is not a downside-free service choice, the duty is not solely the prescriber's, and a patient's insistence does not shield the pharmacist.
- A pharmacist calls a prescriber's office to resolve doubts about a controlled substance order and verifies the diagnosis and treatment plan before dispensing. How does this verification step support corresponding responsibility?
- It is unnecessary because phone calls have no legal weight
- It shifts the entire duty onto the office staff who answered
- It demonstrates the pharmacist took reasonable steps to satisfy the corresponding responsibility duty
- It makes future review of that patient unnecessary
Correct answer: It demonstrates the pharmacist took reasonable steps to satisfy the corresponding responsibility duty
Calling to verify the diagnosis and treatment plan demonstrates the pharmacist took reasonable steps to satisfy corresponding responsibility. Such verification carries real weight, does not transfer the duty to office staff, and does not exempt the pharmacist from reviewing future prescriptions for that patient.
- A pharmacist must analyze whether corresponding responsibility ever requires refusing to fill an otherwise technically valid controlled substance prescription. What is the soundest conclusion?
- A technically valid prescription must always be filled regardless of concerns
- The pharmacist may refuse only if the patient is uninsured
- Refusal is never permitted once a prescription is technically complete
- Corresponding responsibility can require refusal when the pharmacist cannot resolve doubts about legitimacy despite a technically complete order
Correct answer: Corresponding responsibility can require refusal when the pharmacist cannot resolve doubts about legitimacy despite a technically complete order
Corresponding responsibility can require refusal when the pharmacist cannot resolve genuine doubts about legitimacy, even if the order is technically complete. A facially valid prescription is not an absolute mandate to dispense, refusal is permitted in this situation, and insurance status is irrelevant to the decision.
- A pharmacist notices that a patient pays cash for high-dose opioid prescriptions even though the patient has active prescription insurance. Why can paying cash to avoid insurance be treated as a red flag?
- Because cash payment is illegal for controlled substances
- Because insurance is mandatory for all prescriptions
- Because cash patients are entitled to larger quantities
- Because it may indicate an attempt to avoid insurance review or detection of overlapping therapy
Correct answer: Because it may indicate an attempt to avoid insurance review or detection of overlapping therapy
Paying cash despite having insurance can be a red flag because it may signal an attempt to avoid insurance utilization review or detection of overlapping therapy. Cash payment is not illegal, does not entitle a patient to larger quantities, and insurance is not mandatory for filling a prescription.
- A pharmacist sees several different patients present sequential, consecutively numbered prescription blanks from the same prescriber for the same controlled substance on the same day. Why does this raise concern?
- Because consecutively numbered blanks prove the prescriptions are valid
- Because it can indicate prescription pad misuse or pattern prescribing warranting investigation
- Because prescription blanks are never numbered
- Because the pharmacy must dispense them in numerical order
Correct answer: Because it can indicate prescription pad misuse or pattern prescribing warranting investigation
Sequential, consecutively numbered blanks for the same drug from one prescriber can indicate prescription pad misuse or pattern prescribing that warrants investigation. The numbering does not prove validity, blanks can be numbered, and there is no rule requiring dispensing in numerical order.
- A pharmacist encounters a controlled substance prescription that appears altered, with the quantity changed in different handwriting and ink. When a possible alteration red flag arises, what is the most appropriate response?
- Dispense the higher quantity to satisfy the patient
- Verify the original order directly with the prescriber before dispensing and do not honor the apparent alteration
- Erase the change and use the lower number without verification
- Assume the patient corrected an error and proceed
Correct answer: Verify the original order directly with the prescriber before dispensing and do not honor the apparent alteration
An apparent alteration requires verifying the original order directly with the prescriber before dispensing, without honoring the suspect change. Dispensing the higher quantity, silently using the lower number, or assuming the patient legitimately corrected the order all bypass the needed verification.
- A pharmacist transfers an authorized refill of a Schedule IV prescription to another pharmacy by telephone. What is required of the two pharmacists involved in this communication?
- The transfer may be relayed through a technician on each end
- The transfer must be communicated directly between two licensed pharmacists
- The patient must read the prescription details to the receiving pharmacy
- A prescriber must personally make the transfer call
Correct answer: The transfer must be communicated directly between two licensed pharmacists
A controlled substance refill transfer by phone must be communicated directly between two licensed pharmacists. It cannot be relayed solely through technicians, cannot be conveyed by the patient reading the details, and does not require the prescriber to make the call.
- When a Schedule III prescription is transferred for refill, the transferring pharmacist must take a specific action on the original record to prevent further dispensing. What must the transferring pharmacist do?
- Write the word 'void' on the face of the transferred-out original prescription
- Discard the original prescription immediately
- Mail the original to the receiving pharmacy
- Increase the refill count before transfer
Correct answer: Write the word 'void' on the face of the transferred-out original prescription
The transferring pharmacist must write 'void' on the face of the transferred-out original prescription so it cannot be dispensed again at the original pharmacy. Discarding it destroys the required record, mailing the original is not the procedure, and increasing the refill count is improper.
- A pharmacist completing a controlled substance refill transfer must record information identifying who handled the transaction on each side. Which identifying detail must be documented for the transfer?
- The favorite color of each pharmacist
- The names of the transferring and receiving pharmacists and the pharmacies involved
- The home phone numbers of both pharmacists
- The square footage of each pharmacy
Correct answer: The names of the transferring and receiving pharmacists and the pharmacies involved
A controlled substance refill transfer must document the names of the transferring and receiving pharmacists and the pharmacies involved. Personal preferences, home phone numbers, and store square footage are not part of the required transfer documentation.
- A patient asks why a Schedule III prescription with two remaining refills can be transferred only one time for refill purposes between non-networked pharmacies. Analyzing the federal rule, what is the correct explanation?
- There is no limit on how many times such a prescription may be transferred
- Schedule III prescriptions cannot be transferred at all
- The prescription may be transferred unlimited times if the patient consents
- Federal rules permit a single transfer of refills for Schedule III-V drugs between pharmacies not sharing a real-time database
Correct answer: Federal rules permit a single transfer of refills for Schedule III-V drugs between pharmacies not sharing a real-time database
Federal rules permit a single transfer of refills for Schedule III-V drugs between pharmacies that do not share a real-time database. There is a limit when no shared database exists, patient consent does not create unlimited transfers, and Schedule III prescriptions are not categorically non-transferable.
- During prospective drug utilization review, the pharmacist screens for a situation where the prescribed dose is far higher than typical for the patient's age and condition. Which screening category does this represent?
- Underutilization
- Therapeutic duplication
- Drug-allergy interaction
- Over-utilization or incorrect dosage
Correct answer: Over-utilization or incorrect dosage
A dose far higher than typical for the patient's age and condition falls under over-utilization or incorrect dosage screening in prospective drug utilization review. Therapeutic duplication, drug-allergy interaction, and underutilization describe different categories of medication-related problems.
- A pharmacist screens a new prescription against the patient's profile and identifies a documented penicillin allergy with an order for an antibiotic in that class. Which prospective drug utilization review category is triggered?
- Incorrect duration of therapy
- Drug-allergy interaction
- Therapeutic duplication
- Clinical misuse
Correct answer: Drug-allergy interaction
Ordering an antibiotic in a class to which the patient has a documented allergy triggers the drug-allergy interaction category of prospective drug utilization review. Incorrect duration, therapeutic duplication, and clinical misuse are separate screening categories not represented by this allergy conflict.
- A pharmacist analyzes when prospective drug utilization review should occur relative to the dispensing process. At what point must this review be performed?
- After the patient has already taken the medication
- Only during the annual pharmacy inspection
- Before the drug is dispensed to the patient
- Only when the prescriber requests it
Correct answer: Before the drug is dispensed to the patient
Prospective drug utilization review must be performed before the drug is dispensed, so problems can be caught before the patient receives the medication. Reviewing after the patient has taken it, only at inspection, or only on prescriber request would defeat the prospective, preventive purpose of the review.
- A pharmacist identifies a serious drug-drug interaction during prospective drug utilization review and contacts the prescriber, who agrees to change therapy. How should this intervention be handled in the record?
- Document the identified problem, the prescriber contact, and the resolution
- No notation is needed because the problem was resolved
- Record only that the prescription was dispensed
- Note the interaction but not the resolution
Correct answer: Document the identified problem, the prescriber contact, and the resolution
The pharmacist should document the identified interaction, the prescriber contact, and the resolution to show the review and intervention occurred. Omitting any notation, recording only that dispensing happened, or noting the problem without the resolution would leave the prospective review inadequately documented.
- Many state prescription drug monitoring programs require dispensing data to be uploaded within a defined timeframe after the controlled substance is dispensed. What is the general trend in modern reporting timeframes?
- Increasingly frequent, often daily or near real-time reporting
- Reporting only once per year
- Reporting only when a patient files a complaint
- No defined timeframe in any state
Correct answer: Increasingly frequent, often daily or near real-time reporting
Modern prescription drug monitoring programs increasingly require frequent uploads, often daily or near real-time, to keep the data useful for clinical decisions. Annual-only reporting, complaint-triggered reporting, and a complete absence of timeframes do not reflect current monitoring-program practice.
- A pharmacist wants to understand who may lawfully access prescription drug monitoring program data. Which group is typically authorized to query the database for patient care?
- Any member of the general public
- Marketing companies seeking patient lists
- Licensed prescribers and pharmacists involved in the patient's care
- The patient's employer
Correct answer: Licensed prescribers and pharmacists involved in the patient's care
Prescription drug monitoring program data is typically accessible to licensed prescribers and pharmacists involved in the patient's care. The general public, marketing companies, and a patient's employer are not authorized to query the protected controlled substance dispensing data.
- A pharmacist dispenses a non-controlled cholesterol medication and wonders whether it must be reported to the prescription drug monitoring program. What is the correct understanding of what these programs track?
- They track every prescription regardless of schedule
- They track only over-the-counter products
- They generally track dispensed controlled substances rather than non-controlled drugs
- They track only compounded preparations
Correct answer: They generally track dispensed controlled substances rather than non-controlled drugs
Prescription drug monitoring programs generally track dispensed controlled substances rather than non-controlled medications, so a routine cholesterol drug usually is not reported. They do not capture every prescription regardless of schedule, are not limited to over-the-counter products, and are not restricted to compounded preparations.
- A pharmacist analyzes how using the prescription drug monitoring program supports safe dispensing beyond simply detecting abuse. Which additional benefit is accurate?
- It guarantees lower drug prices for patients
- It replaces the need for any patient counseling
- It can reveal duplicate therapy and dangerous combinations across multiple prescribers and pharmacies
- It eliminates the need for prescriber authorization
Correct answer: It can reveal duplicate therapy and dangerous combinations across multiple prescribers and pharmacies
Beyond detecting abuse, the monitoring program can reveal duplicate therapy and dangerous drug combinations spanning multiple prescribers and pharmacies. It does not control drug prices, does not replace counseling, and does not remove the requirement for prescriber authorization.
- A pharmacy submits its required controlled substance dispensing report to the state monitoring program but later discovers an error in a reported entry. Analyzing the obligation, what should the pharmacy do?
- Ignore the error since the report was already sent
- Delete the patient's entire history
- Correct the erroneous entry through the program's correction or resubmission process
- Wait for the state to discover the error
Correct answer: Correct the erroneous entry through the program's correction or resubmission process
A discovered reporting error should be corrected through the monitoring program's correction or resubmission process to keep the data accurate. Ignoring the error, deleting the patient's history, or waiting for the state to find it all leave inaccurate data in a system relied on for safety.
- A pharmacist explains to a student why prescription drug monitoring programs exist as a public-health tool. Which statement best captures the core purpose?
- To track controlled substance dispensing so clinicians can identify misuse, diversion, and unsafe use
- To set wholesale prices for controlled substances
- To advertise pharmacies to new patients
- To replace the controlled substance schedules
Correct answer: To track controlled substance dispensing so clinicians can identify misuse, diversion, and unsafe use
Monitoring programs exist to track controlled substance dispensing so clinicians can identify misuse, diversion, and unsafe use. They do not set wholesale prices, serve as advertising, or replace the controlled substance scheduling system.
- A pharmacist receives a Schedule II prescription and dispenses only part of the quantity because the patient requests less at the moment. Within what timeframe must the remaining quantity generally be provided when the partial fill is at the patient's request?
- Within 30 days of the date the prescription was written
- Within 72 hours regardless of circumstance
- Within one year automatically
- There is no time limit at all
Correct answer: Within 30 days of the date the prescription was written
When a Schedule II partial fill is at the patient's request, the remaining quantity must generally be provided within 30 days of the date the prescription was written. The 72-hour window applies to the inadequate-stock situation, a one-year automatic window is incorrect, and a complete absence of a time limit does not apply.
- A pharmacist partially fills a Schedule II prescription due to insufficient stock and is unable to supply the balance within the permitted window. What must happen to the unfilled remainder of the prescription?
- It may be supplied at any later time without restriction
- The remaining portion can no longer be dispensed on that prescription and a new prescription is needed
- It automatically converts into refills
- It transfers to a Schedule III status
Correct answer: The remaining portion can no longer be dispensed on that prescription and a new prescription is needed
If the balance of an inadequate-stock Schedule II partial fill cannot be supplied within the permitted window, the remaining portion can no longer be dispensed on that prescription and a new one is required. The balance is not available indefinitely, does not convert into refills, and does not change the drug's schedule.
- A pharmacist must determine the recordkeeping needed when a Schedule II prescription is partially filled. What must be recorded at the time of each partial fill?
- The quantity dispensed and the date of each partial fill on the prescription record
- Only the patient's insurance plan name
- The pharmacy's monthly sales figure
- The prescriber's medical school
Correct answer: The quantity dispensed and the date of each partial fill on the prescription record
Each Schedule II partial fill requires recording the quantity dispensed and the date of that partial fill on the prescription record so the cumulative total stays within the amount prescribed. The insurance plan name, the pharmacy's sales figure, and the prescriber's medical school are not the required partial-fill entries.
- A pharmacist analyzes whether partially filling a Schedule II prescription ever allows dispensing more total medication than the prescriber ordered. What is the correct conclusion?
- Yes, partial fills allow exceeding the ordered amount as a service
- Yes, if the patient signs a waiver
- No, the sum of all partial fills may never exceed the total quantity prescribed
- Yes, if completed within 72 hours
Correct answer: No, the sum of all partial fills may never exceed the total quantity prescribed
Across all partial fills, the cumulative quantity may never exceed the total amount the prescriber ordered. There is no service exception, no patient waiver, and no 72-hour completion provision that would permit dispensing more than the prescribed total.
- A prescription label for a dispensed medication must identify the responsible prescriber so the patient and providers can trace the order. Which prescriber detail must appear on the label?
- The prescriber's undergraduate major
- The prescriber's personal bank account
- The prescriber's vehicle license plate
- The prescriber's name
Correct answer: The prescriber's name
A dispensed prescription label must include the prescriber's name to identify who authorized the medication. The prescriber's bank account, license plate, and undergraduate major are unrelated to the labeling requirement.
- A pharmacist verifies that a dispensed prescription label includes a serial or prescription number. What purpose does this number serve on the label?
- It uniquely identifies the prescription record for tracking and refilling
- It sets the retail price of the drug
- It indicates the patient's credit score
- It lists the manufacturer's profit margin
Correct answer: It uniquely identifies the prescription record for tracking and refilling
The serial or prescription number on the label uniquely identifies the prescription record so it can be tracked and refilled. It does not set the price, indicate a credit score, or represent any profit margin.
- A pharmacist dispenses a medication and must ensure the label states when the prescription was filled. Which date element belongs on the dispensing label?
- The date the patient was born only
- The date the pharmacy opened for business
- The date the prescription was filled or dispensed
- The date the drug patent expires
Correct answer: The date the prescription was filled or dispensed
The dispensing label must show the date the prescription was filled or dispensed so the medication's timeline is clear. The patient's birth date alone, the pharmacy's opening date, and the drug's patent-expiration date are not the required dispensing date.
- A pharmacist reviews a dispensed label to confirm the drug is identified for the patient. How should the medication itself be represented on the label when the actual product is dispensed?
- By the drug name and strength of the medication dispensed
- By a code known only to the pharmacy computer
- By the wholesaler's internal item number only
- By the color of the tablet alone
Correct answer: By the drug name and strength of the medication dispensed
The label should identify the medication by its drug name and strength so the patient knows what was dispensed. A pharmacy-only code, a wholesaler item number, or merely the tablet color does not adequately identify the medication for the patient.
- A pharmacist analyzes why a dispensing label must include directions for use even when the prescriber wrote 'use as directed' on the order. What is the best practice and rationale?
- Copy 'use as directed' verbatim because that is always sufficient
- Print only the drug name and omit directions
- Leave the directions blank to save space
- Clarify the directions so the label communicates how the patient should actually take the medication
Correct answer: Clarify the directions so the label communicates how the patient should actually take the medication
Best practice is to clarify the directions so the label tells the patient how to actually take the medication, rather than relying on a vague 'use as directed.' Copying the vague phrase verbatim, leaving directions blank, or omitting directions entirely undermines safe patient use.
- A pharmacist applies an auxiliary label warning that a medication may interact dangerously with alcohol. What is the function of this auxiliary warning?
- To alert the patient to avoid alcohol because of a potential harmful interaction
- To advertise the manufacturer's brand
- To indicate the drug must be refrigerated
- To replace the patient's directions for use
Correct answer: To alert the patient to avoid alcohol because of a potential harmful interaction
An alcohol-warning auxiliary label alerts the patient to avoid alcohol because of a potentially harmful interaction with the medication. It is not promotional, does not address refrigeration, and does not replace the primary directions for use.
- A pharmacist dispenses an antibiotic that should be taken until completely finished to prevent treatment failure. Which auxiliary label best supports this instruction?
- 'May cause drowsiness'
- 'Take until all medication is gone'
- 'For external use only'
- 'Store in the freezer'
Correct answer: 'Take until all medication is gone'
The 'Take until all medication is gone' auxiliary label best supports finishing the full antibiotic course to prevent treatment failure. A drowsiness warning, an external-use-only label, and a freezer-storage label address unrelated concerns for this product.
- A pharmacist must select an auxiliary label for an extended-release tablet that loses its controlled-release property if crushed or chewed. Which auxiliary instruction is appropriate?
- 'Chew thoroughly before swallowing'
- 'Swallow whole; do not crush or chew'
- 'Dissolve in water before taking'
- 'Take with grapefruit juice'
Correct answer: 'Swallow whole; do not crush or chew'
An extended-release tablet that must keep its controlled-release property should bear a 'Swallow whole; do not crush or chew' auxiliary label. Instructions to chew, dissolve in water, or take with grapefruit juice would defeat or complicate the extended-release design.
- A pharmacist analyzes the legal status of auxiliary labels relative to the primary dispensing label directions. Which statement is most accurate?
- Auxiliary labels supersede and replace the primary directions
- Auxiliary labels supplement the primary directions with additional safety or handling information
- Auxiliary labels are required to be printed in place of the drug name
- Auxiliary labels are decorative and convey no medical information
Correct answer: Auxiliary labels supplement the primary directions with additional safety or handling information
Auxiliary labels supplement the primary directions by adding safety or handling information without replacing them. They do not supersede the directions, are not printed in place of the drug name, and are not merely decorative.
- The Poison Prevention Packaging Act generally requires that most oral prescription drugs for human use be dispensed in special packaging. What is the purpose of this special packaging?
- To make the medication easier for young children to open
- To significantly reduce the risk that young children can open the container and access the contents
- To extend the drug's shelf life only
- To reduce manufacturing costs
Correct answer: To significantly reduce the risk that young children can open the container and access the contents
The special packaging required by the Poison Prevention Packaging Act is designed to significantly reduce the risk that young children can open the container and reach the contents. It is not meant to make access easier for children, is not primarily about shelf life, and is not a cost-reduction measure.
- A pharmacist recalls that certain drugs are exempt from child-resistant packaging because they need to be rapidly accessible in an emergency. Which type of product reflects such an exemption?
- A daily oral antibiotic tablet
- A standard oral antihypertensive capsule
- Sublingual nitroglycerin used for acute chest pain
- A routine oral antihistamine
Correct answer: Sublingual nitroglycerin used for acute chest pain
Sublingual nitroglycerin is a recognized exemption from child-resistant packaging because it must be rapidly accessible during acute chest pain. A daily antibiotic, a routine antihypertensive capsule, and a routine antihistamine do not carry that emergency-access exemption.
- A prescriber writes on a prescription that the medication may be dispensed in a non-child-resistant container. How may the pharmacist treat this prescriber instruction under the Poison Prevention Packaging Act?
- It must be ignored because only patients may waive packaging
- It converts the drug to over-the-counter status
- It permits non-child-resistant packaging for all of that patient's future drugs
- A prescriber may request non-child-resistant packaging for that specific prescription
Correct answer: A prescriber may request non-child-resistant packaging for that specific prescription
Under the Act, a prescriber may request non-child-resistant packaging for that specific prescription. The instruction is not ignored, does not blanket-waive packaging for all future drugs, and does not change the drug's prescription status.
- A pharmacist must analyze whether a single, blanket request can waive child-resistant packaging for every prescription a patient ever receives. What is the correct interpretation under the Poison Prevention Packaging Act?
- A patient may give a blanket waiver for all future prescriptions, which is broadly accepted
- A prescriber may waive packaging only on a per-prescription basis, while a patient may request non-child-resistant packaging more broadly subject to documentation
- No waiver of any kind is permitted under the Act
- Only the manufacturer can authorize non-child-resistant packaging
Correct answer: A prescriber may waive packaging only on a per-prescription basis, while a patient may request non-child-resistant packaging more broadly subject to documentation
Under the Act, a prescriber's waiver is limited to the specific prescription, whereas a patient may request non-child-resistant packaging more broadly subject to documentation. The packaging waiver framework does permit patient and prescriber requests, so a blanket no-waiver rule and manufacturer-only authorization are both incorrect.
- A pharmacist evaluates whether a refill of an oral medication previously dispensed in child-resistant packaging must again use child-resistant packaging absent any waiver. What is the correct conclusion?
- Refills are exempt from child-resistant packaging requirements
- Each fill and refill of a covered drug requires child-resistant packaging unless a valid waiver applies
- Only the first fill needs child-resistant packaging
- Child-resistant packaging is required only for controlled substances
Correct answer: Each fill and refill of a covered drug requires child-resistant packaging unless a valid waiver applies
Each fill and refill of a covered oral medication requires child-resistant packaging unless a valid patient or prescriber waiver applies. Refills are not exempt, the requirement is not limited to the first fill, and it is not restricted to controlled substances.
- A pharmacist analyzes why an oral contraceptive in a manufacturer's dispensing package is treated differently under the Poison Prevention Packaging Act. What explains this treatment?
- Oral contraceptives are not drugs
- Oral contraceptives are always controlled substances
- Certain unit-dose or manufacturer-dispensed packages for specific products have recognized exemptions or special packaging provisions
- The Act does not apply to any women's health products
Correct answer: Certain unit-dose or manufacturer-dispensed packages for specific products have recognized exemptions or special packaging provisions
Certain unit-dose or manufacturer-dispensed packages, including some oral contraceptive products, have recognized exemptions or special packaging provisions under the Act. Oral contraceptives are drugs, are not controlled substances, and the Act does not categorically exclude women's health products.
- Under the Combat Methamphetamine Epidemic Act, products containing regulated precursors such as pseudoephedrine must be stored in a particular way at retail. How must these products be kept?
- On an open shelf accessible to any customer
- Mailed directly to customers only
- In the pharmacy refrigerator at all times
- Behind the counter or in a locked cabinet, not on an open sales floor
Correct answer: Behind the counter or in a locked cabinet, not on an open sales floor
The Combat Methamphetamine Epidemic Act requires pseudoephedrine products to be kept behind the counter or in a locked cabinet rather than on an open sales floor. Open-shelf access, refrigerated storage, and mail-only distribution do not satisfy the law's storage controls.
- A customer wishes to purchase a pseudoephedrine product. What must the seller verify before completing the sale under the Combat Methamphetamine Epidemic Act?
- The purchaser's height and weight
- The purchaser's employer
- The purchaser's photo identification
- The purchaser's blood type
Correct answer: The purchaser's photo identification
Before completing a pseudoephedrine sale, the seller must verify the purchaser's photo identification under the Combat Methamphetamine Epidemic Act. The purchaser's employer, physical measurements, and blood type are not part of the required verification.
- A pharmacy clerk completing a regulated pseudoephedrine sale must obtain the purchaser's confirmation that the recorded information is accurate. How is this confirmation accomplished?
- The purchaser signs the logbook or electronic record
- The purchaser recites a memorized passcode
- The purchaser pays an extra fee
- The purchaser provides a fingerprint to the manufacturer
Correct answer: The purchaser signs the logbook or electronic record
The purchaser confirms the accuracy of a regulated pseudoephedrine sale by signing the logbook or electronic record. Reciting a passcode, paying a fee, or providing a fingerprint to the manufacturer are not the required confirmation steps.
- A regulated pseudoephedrine purchaser becomes upset that the sale was delayed for identity verification and logbook entry. Analyzing the seller's obligation, what is the correct stance?
- Complete the required identity verification and recordkeeping before any sale, even if the customer objects
- Skip the verification to keep the customer satisfied
- Refer the customer to an open shelf instead
- Sell two packages to make up for the delay
Correct answer: Complete the required identity verification and recordkeeping before any sale, even if the customer objects
The seller must complete the required identity verification and recordkeeping before any pseudoephedrine sale, even if the customer objects. Skipping verification, redirecting to an open shelf, or selling additional packages all violate the precursor-control requirements.
- A behind-the-counter product is kept in the pharmacy area and provided only after consultation, though no prescription is required. Who typically must be involved before the sale of such a behind-the-counter product?
- Only the patient acting alone
- Only a store cashier at the front register
- A pharmacist or trained pharmacy staff under the pharmacist's supervision
- Only a delivery courier
Correct answer: A pharmacist or trained pharmacy staff under the pharmacist's supervision
A behind-the-counter product is typically provided only with involvement of a pharmacist or trained pharmacy staff under the pharmacist's supervision. A front-register cashier, the patient alone, or a courier does not satisfy the staff-interaction expectation for these products.
- A pharmacy wants to know how a non-prescription drug differs from a prescription drug in terms of how a consumer obtains it. Which distinction is correct?
- A non-prescription drug always requires a prescriber's order
- A non-prescription drug is automatically a controlled substance
- A non-prescription drug can never be sold in a pharmacy
- A non-prescription drug may be obtained without a prescriber's order because it can be used safely with label directions
Correct answer: A non-prescription drug may be obtained without a prescriber's order because it can be used safely with label directions
A non-prescription drug may be obtained without a prescriber's order because it can be used safely following its label directions. It does not require an order, can certainly be sold in a pharmacy, and is not automatically a controlled substance.
- A pharmacist is asked whether emergency contraception kept behind the counter and provided after staff interaction, but without a prescription, fits the behind-the-counter model. What is the most accurate response?
- No, because anything behind the counter requires a prescription
- Yes, a product provided without a prescription but after pharmacy-staff interaction reflects the behind-the-counter distribution model
- No, because behind-the-counter products do not exist
- Yes, but only if it is a Schedule II drug
Correct answer: Yes, a product provided without a prescription but after pharmacy-staff interaction reflects the behind-the-counter distribution model
A product provided without a prescription but only after pharmacy-staff interaction reflects the behind-the-counter distribution model. Behind-the-counter status does not require a prescription, behind-the-counter products do exist, and the model is not limited to Schedule II drugs.
- A pharmacist evaluates how to handle a non-prescription product that a manufacturer recommends be sold only after a brief screening for contraindications. Analyzing the distribution choice, what is the appropriate approach?
- Place it on an open shelf with no interaction
- Refuse to stock it entirely
- Require a full prescription from a physician for every purchase
- Keep it accessible only through pharmacy staff who can perform the recommended screening before sale
Correct answer: Keep it accessible only through pharmacy staff who can perform the recommended screening before sale
A non-prescription product needing a brief contraindication screening should be kept accessible only through pharmacy staff who can perform that screening before sale, consistent with the behind-the-counter approach. Open-shelf placement skips the screening, requiring a prescription overstates the control, and refusing to stock it is unnecessary.
- A pharmacist analyzes the boundary between a behind-the-counter non-prescription product and a true over-the-counter product on shelf. Which factor most clearly separates the two?
- The price charged at checkout
- Whether the product is restricted to pharmacy-staff distribution despite needing no prescription
- The color of the product packaging
- Whether the product is sold on weekends
Correct answer: Whether the product is restricted to pharmacy-staff distribution despite needing no prescription
The clearest separator is whether the product is restricted to pharmacy-staff distribution despite needing no prescription, which defines the behind-the-counter category. Price, packaging color, and weekend availability do not determine whether a product is behind-the-counter or freely available over-the-counter.
- A pharmacist dispenses naloxone to a community member under a pharmacist standing order. What essential service should accompany the dispensing of this opioid-overdose reversal agent?
- A requirement that the recipient enroll in a treatment program first
- A prohibition on giving the product to anyone but the at-risk individual
- A mandatory waiting period of several days
- Instruction on recognizing an overdose and administering the naloxone
Correct answer: Instruction on recognizing an overdose and administering the naloxone
Dispensing naloxone under a standing order should be accompanied by instruction on recognizing an overdose and administering the product so it can be used effectively. There is no requirement to enroll in treatment first, no mandatory multi-day waiting period, and dispensing is not limited to the at-risk individual alone.
- A pharmacist analyzes how a statewide standing order expands naloxone access compared with requiring each patient to obtain an individual prescription. Which outcome best describes the effect?
- It allows pharmacists to dispense naloxone under a single prescriber-authorized protocol, broadening timely access
- It restricts naloxone to hospital settings only
- It eliminates any need to instruct recipients
- It reclassifies naloxone as a controlled substance
Correct answer: It allows pharmacists to dispense naloxone under a single prescriber-authorized protocol, broadening timely access
A statewide standing order lets pharmacists dispense naloxone under a single prescriber-authorized protocol, broadening timely access without individual prescriptions. It does not confine naloxone to hospitals, does not remove the need to instruct recipients, and does not reclassify naloxone as a controlled substance.
- A pharmacy needs to order a supply of oxycodone, a Schedule II controlled substance, from its wholesaler using a paper ordering system. Which DEA form must the registrant use to place this order?
- DEA Form 222
- DEA Form 224
- DEA Form 106
- DEA Form 41
Correct answer: DEA Form 222
DEA Form 222 is the required document for ordering Schedule I and Schedule II controlled substances through the paper system. Form 224 is the pharmacy's own registration application, Form 106 reports theft or loss, and Form 41 documents destruction of controlled substances. Ordering CII drugs is the specific function tied to Form 222.
- A pharmacy submits a paper DEA Form 222 to its supplier for a Schedule II order but receives only part of the quantity, with the rest shipped later. Within what timeframe must the supplier deliver any remaining items associated with that single order form?
- Within 14 days of the order date
- Within 60 days of the order date
- Within 30 days of the order date
- Within 90 days of the order date
Correct answer: Within 60 days of the order date
A supplier must complete delivery of items on a single DEA Form 222 within 60 days of the date the order was executed. Quantities not supplied within that window are treated as not furnished and require a new order. The 14-, 30-, and 90-day options do not match the federal 60-day limit for completing a CII order.
- Why does the Controlled Substance Ordering System (CSOS) provide an advantage over the traditional paper DEA Form 222 process for a high-volume pharmacy?
- It exempts the pharmacy from keeping any record of Schedule II purchases
- It removes the requirement for the pharmacy to hold a DEA registration
- It allows electronic ordering of Schedule II substances with unlimited line items and faster transmission
- It permits Schedule II ordering without any digital certificate or signature
Correct answer: It allows electronic ordering of Schedule II substances with unlimited line items and faster transmission
CSOS is the electronic alternative to the paper DEA Form 222 and permits ordering of Schedule I and II substances electronically, with no line-item limit and quicker turnaround. It still requires a valid DEA registration, records must still be kept, and orders must be signed with a digital certificate, so the other options misstate its function.
- A pharmacist using CSOS to place an electronic order for Schedule II controlled substances must authenticate the order using which security mechanism issued specifically for that purpose?
- A state board of pharmacy license number alone
- A handwritten signature scanned into the system
- A wholesaler-assigned customer account password
- A DEA-issued digital certificate
Correct answer: A DEA-issued digital certificate
CSOS orders are signed using a DEA-issued digital certificate that is tied to an individual authorized to order controlled substances. A scanned handwritten signature, a state license number, or a wholesaler password do not satisfy the digital signing requirement that makes CSOS the electronic equivalent of Form 222.
- A pharmacy discovers that a quantity of hydromorphone has gone missing and a significant loss appears to have occurred. Which DEA form is used to report the theft or significant loss of controlled substances?
- DEA Form 106
- DEA Form 222
- DEA Form 41
- DEA Form 224
Correct answer: DEA Form 106
DEA Form 106 is the report used to document theft or significant loss of controlled substances. Form 222 orders CII drugs, Form 41 records destruction, and Form 224 is the registration application. Reporting a loss is the distinct purpose served by Form 106.
- After discovering a theft of controlled substances, a pharmacy notifies the DEA. When must the pharmacy provide that initial notification to the DEA field office?
- Within 30 days after the next biennial inventory
- Upon discovery of the theft or significant loss
- Only at the time of the pharmacy's annual registration renewal
- Within six months of discovering the loss
Correct answer: Upon discovery of the theft or significant loss
A registrant must notify the DEA Field Division Office of a theft or significant loss promptly upon discovery, in writing, within one business day, and then submit the complete DEA Form 106 within 45 days. Waiting until renewal, the next inventory, or six months later would violate the requirement to report on discovery.
- A pharmacist must dispose of expired controlled substance stock by sending it to a reverse distributor. Which DEA form documents the destruction or disposal of controlled substances?
- DEA Form 106
- DEA Form 222
- DEA Form 41
- DEA Form 224
Correct answer: DEA Form 41
DEA Form 41 is the Registrant Record of Controlled Substances Destroyed and documents disposal of controlled substances. Form 106 reports theft or loss, Form 222 orders CII drugs, and Form 224 registers the pharmacy. Destruction recordkeeping is the function unique to Form 41.
- A consultant reviews a pharmacy's controlled substance disposal log and asks for the standard retention period for controlled substance records, including order forms and destruction documentation. What is the minimum federal retention period?
- One year
- Five years
- Seven years
- Two years
Correct answer: Two years
Federal law requires controlled substance records, including DEA Form 222 order forms and DEA Form 41 destruction records, to be retained for a minimum of two years. One, five, and seven years do not match the federal CSA recordkeeping standard, although some states impose longer requirements.
- A new pharmacy opens and stocks controlled substances for the first time. When the pharmacy first engages in dispensing controlled substances, what type of inventory must be taken?
- An initial inventory of all controlled substances on hand on the date dispensing begins
- A biennial inventory due exactly two years later only
- No inventory until the first DEA inspection occurs
- An inventory limited to Schedule II substances only
Correct answer: An initial inventory of all controlled substances on hand on the date dispensing begins
A registrant must take an initial inventory of all controlled substances on hand when it first engages in dispensing them. Thereafter, a biennial inventory is required at least every two years. Limiting the count to CII drugs or waiting for an inspection would violate the CSA inventory requirements.
- How frequently must an established pharmacy conduct a complete inventory of all controlled substances on hand under federal law?
- At least every six months
- At least every two years
- At least once each calendar year
- At least every five years
Correct answer: At least every two years
The federal biennial inventory requirement obligates a registrant to take a complete controlled substance inventory at least every two years. Six months, one year, and five years do not match the biennial standard, though states may require more frequent counts.
- When a pharmacy conducts its biennial controlled substance inventory, how must Schedule II substances be counted compared to substances in Schedules III through V?
- All schedules may be estimated regardless of quantity
- Schedule II may be estimated, while Schedule III-V must be exact
- Schedule II must be an exact count, while Schedule III-V may be estimated unless the container holds more than 1,000 dosage units
- All schedules must be exactly counted with no estimation allowed
Correct answer: Schedule II must be an exact count, while Schedule III-V may be estimated unless the container holds more than 1,000 dosage units
Schedule II substances require an exact count during inventory, while Schedule III through V may be estimated unless a container holds more than 1,000 dosage units, in which case an exact count is needed. Allowing estimation for CII or requiring exact counts for everything misstates the federal inventory rules.
- A pharmacist explains the controlled substance schedules to a new technician. Which statement correctly describes how the five schedules are organized?
- Schedule V has the highest abuse potential and Schedule I has the lowest
- All five schedules carry identical abuse potential and only differ by drug class
- Only Schedules I and II are controlled, while III through V are over-the-counter products
- Schedule I has the highest abuse potential with no accepted medical use, and abuse potential generally decreases from Schedule II to Schedule V
Correct answer: Schedule I has the highest abuse potential with no accepted medical use, and abuse potential generally decreases from Schedule II to Schedule V
Schedule I substances have the highest abuse potential and no accepted medical use, and abuse potential generally decreases moving from Schedule II down to Schedule V. The other statements reverse the order, flatten the distinctions, or wrongly classify CIII-V as non-controlled.
- A pharmacy receives a drug that has no currently accepted medical use in the United States and the highest potential for abuse. Into which controlled substance schedule does this drug fall?
- Schedule I
- Schedule II
- Schedule IV
- Schedule V
Correct answer: Schedule I
Schedule I is defined by a high potential for abuse combined with no currently accepted medical use, which is why these substances generally cannot be prescribed. Schedule II drugs have accepted medical uses despite high abuse potential, and Schedules IV and V carry progressively lower abuse potential.
- A pharmacist preparing intravenous admixtures in a cleanroom must follow standards designed to ensure these preparations remain free of microbial contamination. Which USP chapter governs sterile compounding?
- USP Chapter 795
- USP Chapter 797
- USP Chapter 800
- USP Chapter 825
Correct answer: USP Chapter 797
USP Chapter 797 sets the standards for sterile compounding to prevent microbial contamination of preparations such as IV admixtures. Chapter 795 covers nonsterile compounding, Chapter 800 addresses hazardous drugs, and Chapter 825 covers radiopharmaceuticals, so 797 is the correct sterile-compounding reference.
- Under USP Chapter 797, why is a beyond-use date assigned to a compounded sterile preparation more conservatively than a manufacturer's expiration date for a commercial product?
- Beyond-use dates are required only for nonsterile products and never for sterile ones
- A beyond-use date is identical to the manufacturer's expiration date in all cases
- Compounded sterile preparations lack the stability and sterility testing of manufactured products, so BUDs limit the risk of contamination and degradation
- Beyond-use dates apply only to controlled substances regardless of compounding
Correct answer: Compounded sterile preparations lack the stability and sterility testing of manufactured products, so BUDs limit the risk of contamination and degradation
Because compounded sterile preparations are not subjected to the full stability and sterility testing applied to commercial products, USP 797 assigns conservative beyond-use dates to control contamination and degradation risk. BUDs apply to both sterile and nonsterile compounds and are distinct from manufacturer expiration dates, so the other options are incorrect.
- A pharmacy compounds a custom oral suspension and a topical ointment from bulk ingredients, with no requirement for sterility. Which USP chapter provides the standards for these nonsterile preparations?
- USP Chapter 797
- USP Chapter 800
- USP Chapter 671
- USP Chapter 795
Correct answer: USP Chapter 795
USP Chapter 795 governs nonsterile compounding such as oral suspensions and topical ointments. Chapter 797 covers sterile compounding, Chapter 800 covers hazardous drugs, and Chapter 671 addresses container performance, so 795 is the applicable standard for nonsterile preparations.
- A pharmacy prepares chemotherapy agents and other antineoplastic medications that pose occupational exposure hazards to staff. Which USP chapter establishes standards for the safe handling of hazardous drugs?
- USP Chapter 800
- USP Chapter 795
- USP Chapter 797
- USP Chapter 1163
Correct answer: USP Chapter 800
USP Chapter 800 sets the standards for handling hazardous drugs, including receipt, storage, compounding, and disposal, to protect personnel and the environment. Chapters 795 and 797 cover nonsterile and sterile compounding respectively, and Chapter 1163 addresses quality assurance, so 800 is the hazardous-drug standard.
- Under USP Chapter 800, how should a pharmacy store hazardous drugs that require refrigeration to limit personnel exposure risk?
- Mixed with patient-specific medications in the main dispensing refrigerator
- In a dedicated refrigerator located within a negative-pressure containment area used only for hazardous drugs
- At room temperature in the general stock area regardless of the labeling
- In any unsecured refrigerator as long as the door is labeled
Correct answer: In a dedicated refrigerator located within a negative-pressure containment area used only for hazardous drugs
USP 800 requires refrigerated hazardous drugs to be stored in a dedicated refrigerator within a negative-pressure containment area to reduce exposure and contamination. Storing them with other medications, at the wrong temperature, or in an uncontrolled space would violate the containment standards designed to protect staff.
- A manufacturer issues a Class I recall for a medication after determining that its use could cause serious adverse health consequences or death. What does the Class I designation indicate about the recalled product?
- The product is unlikely to cause any adverse health consequences
- The defect is only cosmetic and poses no health risk
- There is a reasonable probability that use will cause serious adverse health consequences or death
- The recall is voluntary and the product may continue to be dispensed
Correct answer: There is a reasonable probability that use will cause serious adverse health consequences or death
A Class I recall is the most serious category and indicates a reasonable probability that use of the product will cause serious adverse health consequences or death. Class II involves temporary or reversible harm and Class III involves unlikely harm, so the descriptions of low risk, cosmetic defects, or continued dispensing are incorrect.
- A pharmacy receives notice that a specific lot of a dispensed medication is subject to a drug recall. What is the most appropriate first operational step for the pharmacy?
- Continue dispensing the lot until the current supply is exhausted
- Discard all medications of every lot number in the pharmacy
- Wait for the next biennial inventory before taking any action
- Quarantine and segregate the affected lot from dispensable stock so it cannot be dispensed
Correct answer: Quarantine and segregate the affected lot from dispensable stock so it cannot be dispensed
When a recall notice identifies an affected lot, the pharmacy should immediately quarantine and segregate that lot so it is removed from dispensable stock, then follow the recall instructions. Continuing to dispense the lot, discarding unrelated stock, or waiting for an inventory would either endanger patients or waste good product.
- A recall is classified as Class II rather than Class I. What does the Class II classification communicate about the level of risk posed by the recalled drug product?
- Use may cause temporary or medically reversible adverse health consequences, with a remote probability of serious harm
- Use is virtually certain to cause death
- The product carries no health risk and is recalled only for labeling preferences
- The recall applies only to controlled substances
Correct answer: Use may cause temporary or medically reversible adverse health consequences, with a remote probability of serious harm
A Class II recall indicates that use of the product may cause temporary or medically reversible adverse health consequences, with only a remote probability of serious harm. Class I covers probable serious harm or death and Class III covers products unlikely to cause harm, so the extreme and no-risk descriptions are incorrect.
- A large chain uses one site to perform the data entry, adjudication, and label generation for prescriptions that are then filled and dispensed at neighborhood stores. What is this arrangement called?
- Compounding under USP 797
- Centralized prescription processing
- A biennial inventory transfer
- A power of attorney for ordering
Correct answer: Centralized prescription processing
Centralized prescription processing occurs when one pharmacy performs processing functions such as data entry, adjudication, or label generation on behalf of other pharmacies in the system. It is distinct from compounding, inventory, and ordering authority, which describe unrelated operational functions.
- A central fill pharmacy prepares a labeled, filled prescription and ships it to a retail pharmacy for delivery to the patient. For this arrangement to be permissible, what relationship must generally exist between the central fill pharmacy and the retail pharmacy?
- They must be located in the same building with no shared records
- They may operate with no agreement as long as both hold DEA registrations
- They must share a common owner or have a contractual agreement and access to a shared or linked patient record system
- They must be owned by different companies that have never communicated
Correct answer: They must share a common owner or have a contractual agreement and access to a shared or linked patient record system
Central fill arrangements generally require the central fill and retail pharmacies to share common ownership or a contractual agreement, along with access to shared or linked patient records, so prescriptions can be processed safely across sites. The other options describe arrangements that lack the required relationship or record linkage.
- Before a pharmacy may legally operate and dispense medications in a state, which credential must it obtain from the state board of pharmacy?
- Only the individual pharmacist's license, with no facility credential
- A DEA Form 222 for the building
- A USP 797 certification for the entire store
- A pharmacy permit or license for the practice site
Correct answer: A pharmacy permit or license for the practice site
A pharmacy must hold a permit or license issued by the state board of pharmacy for the practice site before it may operate and dispense. An individual pharmacist license does not authorize the facility, a Form 222 is an order form, and USP 797 governs sterile compounding rather than licensing the whole store.
- During an unannounced inspection, a board of pharmacy inspector asks to examine the pharmacy's controlled substance records and prescription files. What is the pharmacy's obligation in this situation?
- It must permit the authorized inspector to access required records as a condition of holding its permit
- It may refuse access until it consults its corporate attorney days later
- It must provide access only if the inspection was scheduled in advance
- It may deny access because inspections require a court order in every case
Correct answer: It must permit the authorized inspector to access required records as a condition of holding its permit
Holding a pharmacy permit carries the obligation to allow authorized board inspectors to access required records during inspections, including unannounced ones. Demanding advance scheduling, requiring a court order in every case, or delaying access for days would conflict with the conditions attached to the permit.
- A board of pharmacy finds that a pharmacy permit holder repeatedly violated recordkeeping and operational requirements. Which of the following is an example of a disciplinary action a board may take against the pharmacy's permit?
- Issuing the pharmacy a new DEA Form 222 booklet
- Suspension or revocation of the pharmacy's permit
- Requiring the pharmacy to take a biennial inventory earlier than usual only
- Granting the pharmacy automatic permit renewal
Correct answer: Suspension or revocation of the pharmacy's permit
A board may discipline a non-compliant pharmacy by suspending or revoking its permit, among other sanctions. Issuing order forms, adjusting an inventory date, or granting automatic renewal are operational or favorable actions, not disciplinary measures against the permit.
- A wholesaler delivers a Schedule II order to a pharmacy that placed the order on a paper DEA Form 222. Which copy of the executed order form is the pharmacy required to retain?
- The pharmacy discards all copies once the drugs arrive
- The wholesaler keeps every copy and the pharmacy keeps none
- The pharmacy retains its copy of the executed Form 222 as part of its CII records
- Only the DEA retains a copy and the pharmacy keeps none
Correct answer: The pharmacy retains its copy of the executed Form 222 as part of its CII records
When a paper Form 222 order is completed, the purchasing pharmacy retains its copy of the executed form as part of its required Schedule II records. The pharmacy does not discard its copy, and both the purchaser and supplier maintain copies rather than the DEA or wholesaler holding all of them.
- A pharmacy maintains its controlled substance records. How must Schedule II records be kept relative to other records under federal requirements?
- Schedule II records must be interfiled with regular prescription records
- Schedule II records may be discarded after 90 days
- Schedule II records must be stored only at the DEA field office
- Schedule II records must be kept separate from all other records
Correct answer: Schedule II records must be kept separate from all other records
Federal law requires Schedule II records to be maintained separately from all other records, while Schedule III-V records must be either separate or readily retrievable. Interfiling CII records, discarding them early, or storing them at a DEA office would violate the recordkeeping rules.
- A pharmacy plans to destroy a quantity of unusable controlled substances on site and asks how to handle the disposal record. Which statement best reflects proper documentation of the destruction?
- The destruction must be documented on DEA Form 41 and the record retained with the pharmacy's controlled substance records
- Destruction requires no documentation if the quantity is small
- The destruction is reported on DEA Form 222 like an order
- The pharmacy may flush the drugs without any record because disposal is unregulated
Correct answer: The destruction must be documented on DEA Form 41 and the record retained with the pharmacy's controlled substance records
Destruction of controlled substances must be documented on DEA Form 41, with the record kept as part of the pharmacy's controlled substance recordkeeping. Disposal is regulated regardless of quantity, Form 222 is for ordering CII drugs, and undocumented destruction would violate federal requirements.
- A pharmacy technician discovers a small, unexplained shortage of a Schedule III controlled substance during a count and asks whether this triggers a theft or loss report. What factor primarily determines whether a DEA Form 106 must be filed?
- Only whether the missing drug is a Schedule II substance
- Whether the loss is significant, considered in light of factors such as the quantity, the schedule, and whether a pattern exists
- Whether the loss exceeds exactly 100 dosage units in every case
- Whether the pharmacy has had any prior inspection
Correct answer: Whether the loss is significant, considered in light of factors such as the quantity, the schedule, and whether a pattern exists
Whether a Form 106 must be filed turns on whether the loss is significant, judged by factors such as the quantity lost, the schedule of the substance, the likelihood of diversion, and whether a pattern exists. A rigid 100-unit threshold, a CII-only rule, or prior inspection history do not define the significance standard.
- A compounding pharmacy is deciding which standards apply when it prepares a batch of ophthalmic solution intended to be sterile. Which USP chapter must it follow, and why does the sterile designation matter?
- USP 795, because ophthalmic products are always treated as nonsterile
- USP 800, because all ophthalmic products are classified as hazardous drugs
- USP 797, because the preparation must be free of microbial contamination for safe administration to the eye
- USP 825, because eye drops are radiopharmaceuticals
Correct answer: USP 797, because the preparation must be free of microbial contamination for safe administration to the eye
An ophthalmic solution intended to be sterile must be compounded under USP 797, which ensures freedom from microbial contamination required for safe ocular administration. Ophthalmic products are not inherently nonsterile, are not all hazardous, and are not radiopharmaceuticals, so 795, 800, and 825 do not apply here.
- A pharmacy reviews its NIOSH-based list of hazardous drugs to comply with USP 800. What is the primary purpose of identifying which drugs on its formulary are hazardous?
- To determine which drugs can be ordered without a DEA registration
- To decide which prescriptions qualify for unlimited refills
- To set the patient copay amount for each medication
- To apply appropriate containment, handling, and disposal controls based on the drug's risk to personnel
Correct answer: To apply appropriate containment, handling, and disposal controls based on the drug's risk to personnel
Identifying hazardous drugs under USP 800 lets a pharmacy apply the proper containment, handling, and disposal controls based on the occupational risk each drug poses. Hazardous-drug status does not affect DEA registration, refill limits, or copays, which are governed by unrelated rules.
- Under USP 795, a pharmacist assigns a beyond-use date to a compounded nonsterile oral liquid that contains water. Which consideration most directly drives the conservative beyond-use date for an aqueous nonsterile preparation?
- The potential for microbial growth in water-containing formulations
- The DEA schedule of any controlled ingredient
- The patient's insurance formulary tier
- The number of refills authorized on the prescription
Correct answer: The potential for microbial growth in water-containing formulations
For aqueous nonsterile preparations under USP 795, the risk of microbial growth in water-containing formulations is a key driver of a conservative beyond-use date. The controlled-substance schedule, insurance tier, and refill count are administrative or regulatory factors that do not govern the stability-based BUD.
- A pharmacy that uses CSOS for Schedule II ordering must still meet which recordkeeping obligation for those electronic orders?
- It is exempt from retaining any record because the orders are electronic
- It must retain electronic records of CSOS orders for the required retention period and make them available to the DEA
- It must convert each electronic order back to a paper Form 222 for filing
- It must report each CSOS order to the state board within 24 hours
Correct answer: It must retain electronic records of CSOS orders for the required retention period and make them available to the DEA
CSOS does not eliminate recordkeeping; the pharmacy must retain electronic records of its Schedule II orders for the required period and make them available to the DEA. There is no exemption for electronic orders, no requirement to convert them to paper, and no universal 24-hour state reporting rule for CSOS orders.
- A pharmacy is setting up its area for compounding antineoplastic agents and must ensure airflow protects both the preparation and the worker. Under USP 800, what type of air pressure should the hazardous drug compounding room maintain?
- Positive pressure to push hazardous air into adjacent rooms
- Neutral pressure with no directional airflow
- Negative pressure relative to adjacent areas to contain hazardous drug vapors and particles
- Positive pressure identical to a nonhazardous cleanroom
Correct answer: Negative pressure relative to adjacent areas to contain hazardous drug vapors and particles
USP 800 requires the hazardous drug compounding room to maintain negative pressure relative to adjacent areas so that contaminated air is contained rather than escaping. Positive or neutral pressure would allow hazardous vapors and particles to migrate outward, defeating the containment goal that distinguishes hazardous from nonhazardous cleanrooms.
- A board inspector cites a pharmacy because its controlled substance order forms could not be produced during an inspection. Which underlying requirement did the pharmacy most likely fail to meet?
- Submitting a DEA Form 106 for every order placed
- Filing a USP 797 certificate with each Schedule II order
- Obtaining a new pharmacist license before each inspection
- Maintaining required controlled substance records, including order forms, and keeping them available for inspection
Correct answer: Maintaining required controlled substance records, including order forms, and keeping them available for inspection
The pharmacy most likely failed to maintain required controlled substance records, including order forms, and keep them readily available for inspection. Form 106 reports losses rather than orders, USP 797 certificates are unrelated to ordering, and pharmacist licensure is separate from facility recordkeeping.
- A pharmacy receives a partially completed paper DEA Form 222 back from a supplier indicating that one of the requested Schedule II items was unavailable. How should the pharmacy treat the unfilled portion of that order?
- The unfilled portion is voided for that form, and a new order must be placed if the item is still needed
- The unfilled portion automatically rolls onto the next month's order
- The pharmacy may receive the unfilled item at any future date without a new order
- The pharmacy must file a DEA Form 41 for the unfilled item
Correct answer: The unfilled portion is voided for that form, and a new order must be placed if the item is still needed
An item not supplied on a Form 222 within the allowable period is considered not furnished for that order, and the pharmacy must place a new order if it still needs the drug. The unfilled portion does not roll over indefinitely, and Form 41 documents destruction rather than incomplete orders.
- A pharmacy completes its biennial controlled substance inventory. How long must the resulting inventory record be retained and where should it generally be kept?
- For 30 days at the corporate headquarters only
- For at least two years and maintained at the registered location, available for inspection
- For six months at the DEA field office
- Indefinitely with no requirement for accessibility
Correct answer: For at least two years and maintained at the registered location, available for inspection
A biennial inventory record must be retained for at least two years and kept at the registered location so it is available for inspection. A 30-day or six-month period is too short, and storing it inaccessibly or only at headquarters would conflict with the requirement that records be available at the registered site.
- A pharmacy student asks how the abuse potential and prescribing restrictions of a Schedule II drug compare with those of a Schedule IV drug. Which comparison is accurate?
- Schedule IV drugs have higher abuse potential and may not be refilled at all
- Schedule II and Schedule IV drugs share identical refill rules
- Schedule II drugs have higher abuse potential and tighter prescribing and refill restrictions than Schedule IV drugs
- Schedule IV drugs require DEA Form 222 for ordering while Schedule II drugs do not
Correct answer: Schedule II drugs have higher abuse potential and tighter prescribing and refill restrictions than Schedule IV drugs
Schedule II substances carry higher abuse potential and stricter prescribing and refill controls than Schedule IV substances. The reversed-risk option, the claim of identical refill rules, and the assertion that CIV requires Form 222 are all incorrect, since Form 222 is for Schedule I and II ordering.
- A pharmacy operating a central fill model receives a request to centrally fill a Schedule II prescription. What is generally required for a central fill pharmacy to fill controlled substance prescriptions on behalf of a retail pharmacy?
- Only the retail pharmacy needs a DEA registration
- Central fill of controlled substances is prohibited under all circumstances
- The central fill pharmacy may operate without any DEA registration
- Both pharmacies must hold valid DEA registrations and have a shared or contractual relationship permitting central fill of controlled substances
Correct answer: Both pharmacies must hold valid DEA registrations and have a shared or contractual relationship permitting central fill of controlled substances
For controlled substance central fill, both the central fill and retail pharmacies must hold valid DEA registrations and operate under a shared or contractual relationship that permits the arrangement. Requiring only one registration, prohibiting it entirely, or allowing an unregistered central fill site misstate the requirements.
- A consultant audits a pharmacy's controlled substance destruction practices and finds expired CII drugs sent to a reverse distributor without any retained record. Which deficiency does this represent?
- Failure to document the disposal on a DEA Form 41 and retain the destruction record
- Failure to file a DEA Form 222 for the destroyed drugs
- Failure to conduct a daily perpetual inventory of all schedules
- Failure to report the destruction as a theft on DEA Form 106
Correct answer: Failure to document the disposal on a DEA Form 41 and retain the destruction record
Sending controlled substances for destruction without a retained record is a failure to document the disposal on DEA Form 41 and keep that record. Form 222 covers ordering, Form 106 covers theft or loss rather than routine destruction, and daily perpetual inventory of all schedules is not a federal mandate.
- A pharmacy is evaluating whether its theft and loss reporting process is compliant. After notifying the DEA upon discovery of a significant loss, what additional documentation step must the pharmacy complete?
- Submit a DEA Form 41 to authorize replacement stock
- Complete and submit DEA Form 106 to document the theft or significant loss
- File a DEA Form 224 to re-register the pharmacy
- Place a CSOS order to replace the missing controlled substances
Correct answer: Complete and submit DEA Form 106 to document the theft or significant loss
After notifying the DEA upon discovery, the pharmacy must complete and submit DEA Form 106 to formally document the theft or significant loss. Form 41 covers destruction, Form 224 is the registration application, and placing a CSOS order replaces stock but does not document the loss.
- A pharmacy must arrange for a designated individual to sign paper DEA Form 222 orders for Schedule II substances on behalf of the registrant. Which document grants that signing authority?
- A USP 797 sterile compounding certificate
- A DEA Form 106 theft report
- A power of attorney executed by the registrant
- A biennial inventory worksheet
Correct answer: A power of attorney executed by the registrant
Authority to sign DEA Form 222 orders on behalf of the registrant is granted through a power of attorney executed by the registrant. A USP 797 certificate, a Form 106 theft report, and an inventory worksheet do not confer signing authority for controlled substance order forms.
- A pharmacy receives notification of a Class III drug recall on a product it stocks. How does a Class III recall differ from a Class I recall in terms of health risk?
- A Class III recall involves greater risk of death than a Class I recall
- A Class III recall always requires immediate destruction of all stock storewide
- A Class III recall applies only to controlled substances
- A Class III recall involves a product unlikely to cause adverse health consequences, whereas a Class I recall involves probable serious harm or death
Correct answer: A Class III recall involves a product unlikely to cause adverse health consequences, whereas a Class I recall involves probable serious harm or death
A Class III recall involves a product that is unlikely to cause adverse health consequences, while a Class I recall reflects a reasonable probability of serious harm or death. Class III is therefore the least serious category, does not exceed Class I in risk, and is not limited to controlled substances.
- A pharmacy in a state that requires more frequent counts than federal law decides how often to perform its full controlled substance inventory. Which principle should govern its decision?
- The pharmacy must follow the more stringent requirement, conducting inventories at least as often as state law demands
- The pharmacy may follow only federal law and ignore the stricter state requirement
- The pharmacy may skip inventories entirely if it uses CSOS
- The pharmacy must follow whichever standard is least burdensome
Correct answer: The pharmacy must follow the more stringent requirement, conducting inventories at least as often as state law demands
When federal and state controlled substance inventory rules differ, the pharmacy must comply with the more stringent requirement, meaning it inventories at least as often as state law demands. Ignoring the stricter state rule, skipping inventories because of CSOS, or choosing the least burdensome standard would all violate compliance principles.
- A pharmacy stores its controlled substances and must decide on a storage method that satisfies federal security requirements. Which approach is acceptable for storing Schedule II through V controlled substances?
- Leaving them on open shelves in the waiting area for convenience
- Storing them in a securely locked, substantially constructed cabinet or dispersed throughout the stock to deter theft
- Storing them only in a refrigerator regardless of security
- Keeping them in an unlocked drawer accessible to all staff and customers
Correct answer: Storing them in a securely locked, substantially constructed cabinet or dispersed throughout the stock to deter theft
Federal security standards allow controlled substances to be stored either in a securely locked, substantially constructed cabinet or dispersed throughout the non-controlled stock to deter theft. Open shelves, an unlocked drawer, or relying on refrigeration alone would fail to provide the required security.
- A pharmacy manager is comparing the documentation needed when controlled substances leave inventory for different reasons. Which pairing of event and DEA form is correct?
- Routine destruction is reported on Form 106, while theft is documented on Form 41
- Both routine destruction and theft are documented on Form 222
- Routine destruction of expired CII stock is documented on Form 41, while a burglary loss is reported on Form 106
- Neither destruction nor theft requires any DEA form
Correct answer: Routine destruction of expired CII stock is documented on Form 41, while a burglary loss is reported on Form 106
Routine destruction of expired controlled substances is documented on DEA Form 41, while a theft or significant loss such as a burglary is reported on DEA Form 106. Swapping the two forms, using Form 222 for both, or claiming no form is required all misstate the recordkeeping requirements.
- A pharmacy receives a shipment of a Schedule II controlled substance ordered on a paper DEA Form 222. What information must the pharmacy record on the form when the order is received?
- The patient names for whom the drugs will ultimately be dispensed
- The retail price the pharmacy will charge for the drugs
- The prescriber DEA numbers for future prescriptions
- The number of containers received and the date they were received
Correct answer: The number of containers received and the date they were received
When a Schedule II order arrives, the purchaser must record on its copy of the Form 222 the number of containers received and the date of receipt. Patient names, retail pricing, and prescriber DEA numbers are unrelated to documenting receipt of a wholesale CII order.
- A pharmacy compounds both nonsterile creams and sterile injectables. Why must it apply two different USP chapters to these activities rather than a single standard?
- Nonsterile preparations follow USP 795 while sterile preparations follow the more rigorous environmental controls of USP 797
- Both activities fall entirely under USP 800 because all compounding is hazardous
- Sterile and nonsterile compounding are both governed only by USP 795
- Only the injectables require any standard, since creams are unregulated
Correct answer: Nonsterile preparations follow USP 795 while sterile preparations follow the more rigorous environmental controls of USP 797
Nonsterile compounding such as creams is governed by USP 795, while sterile compounding such as injectables must meet the more rigorous environmental and contamination controls of USP 797. Treating all compounding as hazardous, applying only 795 to both, or claiming creams are unregulated misstates the standards.
